Accept Refuse

EUR-Lex Access to European Union law

Back to EUR-Lex homepage

This document is an excerpt from the EUR-Lex website

Document 32009L0002

Commission Directive 2009/2/EC of 15 January 2009 amending, for the purpose of its adaptation to technical progress, for the 31st time, Council Directive 67/548/EEC on the approximation of the laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances (Text with EEA relevance)

OJ L 11, 16.1.2009, p. 6–82 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
Special edition in Croatian: Chapter 13 Volume 034 P. 85 - 161

No longer in force, Date of end of validity: 31/05/2015; Implicitly repealed by 32008R1272

ELI: http://data.europa.eu/eli/dir/2009/2/oj

16.1.2009   

EN

Official Journal of the European Union

L 11/6


COMMISSION DIRECTIVE 2009/2/EC

of 15 January 2009

amending, for the purpose of its adaptation to technical progress, for the 31st time, Council Directive 67/548/EEC on the approximation of the laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances

(Text with EEA relevance)

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

Having regard to the Treaty establishing the European Community,

Having regard to Council Directive 67/548/EEC of 27 June 1967 on the approximation of the laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances (1), and in particular Article 28 thereof,

Whereas:

(1)

Article 4(3) of Directive 67/548/EEC sets out the criteria and the procedure to be followed to harmonise the classification and labelling of substances. Paragraphs 4.1.3, 4.1.4 and 4.1.5 of Annex VI to Directive 67/548/EEC oblige industry to provide information to Member States and Member States to make proposals for harmonised classification and labelling as a matter of urgency, when information becomes available justifying that a substance fulfils the criteria as a mutagenic, carcinogenic or reproductive toxic chemical.

(2)

Annex I to Directive 67/548/EEC contains a list of dangerous substances, together with particulars of the classification and labelling of each substance. That list needs to be updated to include further notified new substances and further existing substances, as well as to adapt certain entries to technical progress. In addition, it is necessary, in that Annex, to delete entries for certain substances.

(3)

Annex I to Directive 67/548/EEC already contains numerous group entries in particular for metal compounds evaluated using a grouping and read across approach based on analogy between substances.

(4)

Annex I to Directive 67/548/EEC also contains certain groups where members of the group are identified and where the classification was derived by applying grouping and read across approaches, notably the petroleum streams and gasses.

(5)

Annex VI to Directive 67/548/EEC states that the data required for classification and labelling may be obtained from a number of different sources, including the results of validated structure-activity relationships and expert judgement.

(6)

The classifications of the nickel compounds listed in this Directive are based on the effects originating from the Ni(2+) ion and on the available data for nickel compounds. The classifications were derived by grouping nickel compounds into categories on the basis of water solubility (e.g. groups insoluble, slightly soluble and soluble nickel compounds respectively). Water solubility was used as an initial criterion to define these categories, based on the argument that nickel substances having similar water solubility will indicate similar bioavailability of the Ni(2+) ion and similar systemic toxicity. This justifies a read across within groups from the substances for which the available adequate test data demonstrate a specific systemic effect to those lacking such test data. For some effects, read across between groups is justified, as similar effects have been observed across the range of water solubility. For example, epidemiological studies show that both soluble and insoluble nickel compounds (at opposite ends of the range of solubility) have local carcinogenic effects in the respiratory tract. There is, therefore, good reason to conclude that slightly soluble compounds (at the middle of this range) have similar carcinogenic properties.

(7)

As part of an evaluation of all the available information for the nickel compounds, water solubility can be used as an approximation of systemic bioavailability of the Ni(2+) ion for many effects and substances.

(8)

The classification and labelling of the substances listed in this Directive should be reviewed if new scientific knowledge becomes available. In this context, noting in particular that the nickel industry has recently submitted preliminary, partial and not peer-reviewed information, special attention should be paid to the outcome of future discussions within the World Health Organisation's International Agency for Research on Cancer on the carcinogenicity of nickel substances, or to any relevant new scientific findings or interpretations of the data used to establish the classifications for the nickel compounds included in this Directive.

(9)

The measures provided for in this Directive are in accordance with the opinion of the Committee on the Adaptation to Technical Progress of the Directives for the Elimination of Technical Barriers to Trade with Dangerous Substances and Preparations,

HAS ADOPTED THIS DIRECTIVE:

Article 1

Directive 67/548/EEC is amended as follows. Annex I is amended as follows:

(a)

the entries corresponding to the entries set out in Annex 1A to this Directive are replaced by the entries set out in that Annex;

(b)

the entries set out in Annex 1B to this Directive are inserted in accordance with the order of the entries set out in Annex I to Directive 67/548/EEC;

(c)

the entries set out in Annex 1C to this Directive are deleted.

Article 2

Member States shall bring into force the laws, regulations and administrative provisions necessary to comply with this Directive by 1 June 2009 at the latest. They shall forthwith communicate to the Commission the text of those provisions and a correlation table between those provisions and this Directive.

When Member States adopt those provisions, they shall contain a reference to this Directive or be accompanied by such a reference on the occasion of their official publication. Member States shall determine how such reference is to be made.

Member States shall communicate to the Commission the text of the main provisions of national law which they adopt in the field covered by this Directive.

Article 3

This Directive shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

Article 4

This Directive is addressed to the Member States.

Done at Brussels, 15 January 2009.

For the Commission

Stavros DIMAS

Member of the Commission


(1)  OJ 196, 16.8.1967, p. 1.


ANNEX 1A

Index No

Chemical name

Notes related to substances

EC No

CAS No

Classification

Labelling

Concentration Limits

Notes related to preparations

001-002-00-4

aluminium lithium hydride

 

240-877-9

16853-85-3

F; R15

C; R35

F; C

R: 15-35

S: (1/2-)7/8-26-36/37/39-43-45

 

 

005-006-00-7

dibutyltin hydrogen borate

E

401-040-5

75113-37-0

Muta. Cat. 3; R68

Repr. Cat. 2; R60-61

T; R48/25

Xn; R21/22

Xi; R41

R43

N; R50-53

T; N

R: 60-61-21/22-41-43-48/25-68-50/53

S: 53-45-60-61

 

 

006-007-00-5

salts of hydrogen cyanide with the exception of complex cyanides such as ferrocyanides, ferricyanides and mercuric oxycyanide and those specified elsewhere in this Annex

A

T+; R26/27/28

R32

N; R50-53

T+; N

R: 26/27/28-32-50/53

S: (1/2-)7-28-29-45-60-61

 

 

006-015-00-9

diuron (ISO);

3-(3,4-dichlorophenyl)-1,1-dimethylurea

 

206-354-4

330-54-1

Carc. Cat. 3; R40

Xn; R22-48/22

N; R50-53

Xn; N

R: 22-40-48/22-50/53

S: (2-)13-36/37-46-60-61

C ≥ 25 %: Xn, N; R22-40-48/22-50/53

10 % ≤ C < 25 %: Xn, N; R40-48/22-50/53

2,5 % ≤ C < 10 %: Xn, N; R40-50/53

1 % ≤ C < 2,5 %: Xn, N; R40-51/53

0,25 % ≤ C < 1 %: N; R51/53

0,025 % ≤ C < 0,25 %: R52/53

 

006-076-00-1

mancozeb (ISO);

manganese ethylenebis(dithiocarbamate) (polymeric) complex with zinc salt

 

8018-01-7

Repr. Cat. 3; R63

R43

N; R50

Xn; N

R: 43-63-50

S: (2-)36/37-46-61

C ≥ 5 %: Xn, N; R43-63-50

2,5 ≤ C < 5 %: Xi, N; R43-50

1 % ≤ C < 2,5 %: Xi; R43

 

006-077-00-7

maneb (ISO);

manganese ethylenebis(dithiocarbamate) (polymeric)

 

235-654-8

12427-38-2

Repr. Cat. 3; R63

Xn; R20

Xi; R36

R43

N; R50-53

Xn; N

R: 20-36-43-63-50/53

S: (2-)36/37-46-60-61

C ≥ 25 %: Xn, N; R20-36-43-63-50/53

20 % ≤ C < 25 %: Xn, N; R36-43-63-50/53

5 % ≤ C < 20 %: Xn, N; R43-63-50/53

2,5 % ≤ C < 5 %: Xi, N; R43-50/53

1 % ≤ C < 2,5 %: Xi, N; R43-51/53

0,25 % ≤ C < 1 %: N; R51/53

0,025 % ≤ C < 0,25 %: R52/53

 

006-084-00-5

carbosulfan (ISO);

2,3-dihydro-2,2-dimethyl-7-benzofuryl [(dibutylamino)thio]methylcarbamate

 

259-565-9

55285-14-8

T+; R26

T; R25

R43

N; R50-53

T+; N

R: 25-26-43-50/53

S: (1/2-)28-36/37-38-45-63-60-61

 

 

006-088-00-7

benfuracarb (ISO);

ethyl N-[2,3-dihydro-2,2-dimethylbenzofuran-7-yloxycarbonyl(methyl)aminothio]-N-isopropyl-β-alaninate

 

82560-54-1

Repr. Cat. 3; R62

T; R23

Xn; R22

N; R50-53

T; N

R: 22-23-62-50/53

S: (1/2-)36/37-45-60-61

 

 

007-002-00-0

nitrogen dioxide; [1]

dinitrogen tetraoxide [2]

 

233-272-6 [1]

234-126-4 [2]

10102-44-0 [1]

10544-72-6 [2]

O; R8

T+; R26

C; R34

O; T+

R: 8-26-34

S: (1/2-)9-26-28-36/37/39-45

C ≥ 10 %: T+; R26-34

5 % ≤ C < 10 %: T; R23-34

1 % ≤ C < 5 %: T; R23-36/37/38

0,5 % ≤ C < 1 %: Xn; R20-36/37/38

0,1 % ≤ C < 0,5 %: Xn; R20

5

015-041-00-X

malathion (ISO);

1,2-bis(ethoxycarbonyl)ethyl O,O-dimethyl phosphorodithioate;

[containing ≤ 0,03 % isomalathion]

 

204-497-7

121-75-5

Xn; R22

R43

N; R50-53

Xn; N

R: 22-43-50/53

S: (2-)24-37-46-60-61

C ≥ 25 %: Xn, N; R22-43-50/53

1 % ≤ C < 25 %: Xi, N; R43-50/53

0,025 % ≤ C < 1 %: N; R50/53

0,0025 % ≤ C < 0,025 %: N; R51/53

0,00025 % ≤ C < 0,0025 %: R52/53

 

015-100-00-X

phoxim (ISO);

α-(diethoxyphosphinothioylimino) phenylacetonitrile

 

238-887-3

14816-18-3

Repr. Cat. 3; R62

Xn; R22

R43

N; R50-53

Xn; N

R: 22-43-62-50/53

S: (2-)36/37-46-60-61

C ≥ 25 %: Xn, N; R22-43-62-50/53

5 % ≤ C < 25 %: Xn, N; R43-62-50/53

1 % ≤ C < 5 %: Xi, N; R43-50/53

0,025 % ≤ C < 1 %: N; R50/53

0,0025 % ≤ C < 0,025 %: N; R51/53

0,00025 % ≤ C < 0,0025 %: R52/53

 

015-102-00-0

tris(2-chloroethyl)phosphate

E

204-118-5

115-96-8

Carc. Cat. 3; R40

Repr. Cat. 2; R60

Xn; R22

N; R51-53

T; N

R: 60-22-40-51/53

S: 53-45-61

 

 

015-155-00-X

glufosinate ammonium (ISO);

ammonium 2-amino-4-(hydroxymethylphosphinyl)butyrate

E

278-636-5

77182-82-2

Repr. Cat. 2; R60

Repr. Cat. 3; R63

Xn; R20/21/22-48/20/22

T

R: 60-20/21/22-48/20/22-63

S: 53-45

 

 

016-009-00-8

disodium sulfide;

sodium sulfide

 

215-211-5

1313-82-2

T; R24

Xn; R22

C; R34

R31

N; R50

T; C; N

R: 22-24-31-34-50

S: (1/2-)26-36/37/39-45-61

 

 

017-009-00-0

ammonium perchlorate;

[containing ≥ 80 % of 0-30 μm particles]

T

232-235-1

7790-98-9

E; R3

O; R9

E

R: 3-9

S: (2-)14-16-36/37

 

 

024-004-00-7

sodium dichromate

E

234-190-3

10588-01-9

O; R8

Carc. Cat. 2; R45

Muta. Cat. 2; R46

Repr. Cat. 2; R60-61

T+; R26

T; R25-48/23

Xn; R21

C; R34

R42/43

N; R50-53

O; T+; N

R: 45-46-60-61-8-21-25-26-34-42/43-48/23-50/53

S: 53-45-60-61

C ≥ 25 %: T+, N; R45-46-60-61-21-25-26-34-42/43-48/23-50/53

10 % ≤ C < 25 %: T+, N; R45-46-60-61-22-26-34-42/43-48/23-51/53

7 % ≤ C < 10 %: T+, N; R45-46-60-61-22-26-36/37/38-42/43-48/20-51/53

5 % ≤ C < 7 %: T, N; R45-46-60-61-22-23-36/37/38-42/43-48/20-51/53

3 % ≤ C < 5 %: T, N; R45-46-60-61-22-23-42/43-48/20-51/53

2,5 % ≤ C < 3 %: T, N; R45-46-60-61-23-42/43-48/20-51/53

1 % ≤ C < 2,5 %: T; R45-46-60-61-23-42/43-48/20-52/53

0,5 % ≤ C < 1 %: T; R45-46-60-61-20-42/43-52/53

0,25 % ≤ C < 0,5 %: T; R45-46-20-42/43-52/53

0,2 % ≤ C < 0,25 %: T; R45-46-20-42/43

0,1 % ≤ C < 0,2 %: T; R45-46-20

3

027-002-00-4

cobalt oxide

 

215-154-6

1307-96-6

Xn; R22

R43

N; R50-53

Xn; N

R: 22-43-50/53

S: (2-)24-37-60-61

C ≥ 25 %: Xn, N; R22-43-50/53

2,5 % ≤ C < 25 %: Xi, N; R43-50/53

1 % ≤ C < 2,5 %: Xi, N; R43-51/53

0,25 % ≤ C < 1 %: N; R51/53

0,025 % ≤ C < 0,25 %: R52/53

 

027-003-00-X

cobalt sulfide

 

215-273-3

1317-42-6

R43

N; R50-53

Xi; N

R: 43-50/53

S: (2-)24-37-60-61

C ≥ 2,5 %: Xi, N; R43-50/53

1 % ≤ C < 2,5 %: Xi, N; R43-51/53

0,25 % ≤ C < 1 %: N; R51/53

0,025 % ≤ C < 0,25 %: R52/53

 

028-003-00-2

nickel monoxide; [1]

nickel oxide; [2]

bunsenite [3]

E

215-215-7 [1]

234-323-5 [2]

- [3]

1313-99-1 [1]

11099-02-8 [2]

34492-97-2 [3]

Carc. Cat. 1; R49

T; R48/23

R43

R53

T

R: 49-43-48/23-53

S: 53-45-61

 

 

028-004-00-8

nickel dioxide

E

234-823-3

12035-36-8

Carc. Cat. 1; R49

T; R48/23

R43

R53

T

R: 49-43-48/23-53

S: 53-45-61

 

 

028-005-00-3

dinickel trioxide

E

215-217-8

1314-06-3

Carc. Cat. 1; R49

T; R48/23

R43

R53

T

R: 49-43-48/23-53

S: 53-45-61

 

 

028-006-00-9

nickel (II) sulfide; [1]

nickel sulfide; [2]

millerite [3]

E

240-841-2 [1]

234-349-7 [2]

- [3]

16812-54-7 [1]

11113-75-0 [2]

1314-04-1 [3]

Carc. Cat. 1; R49

Muta. Cat. 3; R68

T; R48/23

R43

N; R50-53

T; N

R: 49-43-48/23-68-50/53

S: 53-45-60-61

 

 

028-007-00-4

trinickel disulfide;

nickel subsulfide; [1]

heazlewoodite [2]

E

234-829-6 [1]

- [2]

12035-72-2 [1]

12035-71-1 [2]

Carc. Cat. 1; R49

Muta. Cat. 3; R68

T; R48/23

R43

N; R50-53

T; N

R: 49-43-48/23-68-50/53

S: 53-45-60-61

 

 

028-008-00-X

nickel dihydroxide; [1]

nickel hydroxide [2]

E

235-008-5 [1]

234-348-1 [2]

12054-48-7 [1]

11113-74-9 [2]

Carc. Cat. 1; R49

Repr. Cat. 2; R61

Muta. Cat. 3; R68

T; R48/23

Xn; R20/22

Xi; R38

R42/43

N; R50-53

T; N

R: 49-61-20/22-38-42/43-48/23-68-50/53

S: 53-45-60-61

 

 

029-013-00-X

trisodium(2-(α-(3-(4-chloro-6-(2-(2-(vinylsulfonyl)ethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-2-oxido-5-sulfonatophenylazo)benzylidenehydrazino)-4-sulfonatobenzoato)copper(II)

 

407-580-8

130201-51-3

Xi; R41

Xi

R: 41

S: (2-)26-39

 

 

033-005-00-1

arsenic acid and its salts with the exception of those specified elsewhere in this Annex

AE

Carc. Cat. 1; R45

T; R23/25

N; R50-53

T; N

R: 45-23/25-50/53

S: 53-45-60-61

 

 

034-002-00-8

selenium compounds with the exception of cadmium sulphoselenide and those specified elsewhere in this Annex

A

T; R23/25

R33

N; R50-53

T; N

R: 23/25-33-50/53

S: (1/2-)20/21-28-45-60-61

 

 

047-001-00-2

silver nitrate

 

231-853-9

7761-88-8

O; R8

C; R34

N; R50-53

O; C; N

R: 8-34-50/53

S: (1/2-)26-36/37/39-45-60-61

 

 

050-002-00-0

cyhexatin (ISO);

hydroxytricyclohexylstannane;

tri(cyclohexyl)tin hydroxide

 

236-049-1

13121-70-5

Xn; R20/21/22

N; R50-53

Xn; N

R: 20/21/22-50/53

S: (2-)13-60-61

C ≥ 25 %: Xn, N; R20/21/22-50/53

0,025 % ≤ C < 25 %: N; R50/53

0,0025 % ≤ C < 0,025 %: N; R51/53

0,00025 % ≤ C < 0,0025 %: R52/53

 

050-003-00-6

fentin acetate (ISO);

triphenyltin acetate

 

212-984-0

900-95-8

Carc. Cat. 3; R40

Repr. Cat. 3; R63

T+; R26

T; R24/25-48/23

Xi; R37/38-41

N; R50-53

T+; N

R: 24/25-26-37/38-40-41-48/23-63-50/53

S: (1/2-)26-28-36/37/39-45-60-61

C ≥ 25 %: T+, N; R24/25-26-37/38-40-41-48/23-63-50/53

20 % ≤ C < 25 %: T+, N; R21/22-26-37/38-40-41-48/23-63-50/53

10 % ≤ C < 20 %: T+, N; R21/22-26-40-41-48/23-63-50/53

7 % ≤ C < 10 %: T+, N; R21/22-26-36-40-48/20-63-50/53

5 % ≤ C < 7 %: T, N; R21/22-23-36-40-48/20-63-50/53

3 % ≤ C < 5 %: T, N; R21/22-23-40-48/20-50/53

2,5 % ≤ C < 3 %: T, N; R23-40-48/20-50/53

1 % ≤ C < 2,5 %: T, N; R23-40-48/20-51/53

0,25 % ≤ C < 1 %: Xn, N; R20-51/53

0,1 % ≤ C < 0,25 %: Xn; R20-52/53

0,025 % ≤ C < 0,1 %: R52/53

 

050-004-00-1

fentin hydroxide (ISO);

triphenyltin hydroxide

 

200-990-6

76-87-9

Carc. Cat. 3; R40

Repr. Cat. 3; R63

T+; R26

T; R24/25-48/23

Xi; R37/38-41

N; R50-53

T+; N

R: 24/25-26-37/38-40-41-48/23-63-50/53

S: (1/2-)26-28-36/37/39-45-60-61

C ≥ 25 %: T+, N; R24/25-26-37/38-40-41-48/23-63-50/53

20 % ≤ C < 25 %: T+, N; R21/22-26-37/38-40-41-48/23-63-50/53

10 % ≤ C < 20 %: T+, N; R21/22-26-40-41-48/23-63-50/53

7 % ≤ C < 10 %: T+, N; R21/22-26-36-40-48/20-63-50/53

5 % ≤ C < 7 %: T, N; R21/22-23-36-40-48/20-63-50/53

3 % ≤ C < 5 %: T, N; R21/22-23-40-48/20-50/53

2,5 % ≤ C < 3 %: T, N; R23-40-48/20-50/53

1 % ≤ C < 2,5 %: T, N; R23-40-48/20-51/53

0,25 % ≤ C < 1 %: Xn, N; R20-51/53

0,1 % ≤ C < 0,25 %: Xn; R20-52/53

0,025 % ≤ C < 0,1 %: R52/53

 

050-008-00-3

tributyltin compounds, with the exception of those specified elsewhere in this Annex

A

T; R25-48/23/25

Xn; R21

Xi; R36/38

N; R50-53

T; N

R: 21-25-36/38-48/23/25-50/53

S: (1/2-)36/37/39-45-60-61

C ≥ 2,5 %: T, N; R21-25-36/38-48/23/25-50/53

1 % ≤ C < 2,5 %: T, N; R21-25-36/38-48/23/25-51/53

0,25 % ≤ C < 1 %: Xn, N; R22-48/20/22-51/53

0,025 % C < 0,25 %: R52/53

1

050-011-00-X

triphenyltin compounds, with the exception of those specified elsewhere in this Annex

A

T; R23/24/25

N; R50-53

T; N

R: 23/24/25-50/53

S: (1/2-)26-27-28-45-60-61

C ≥ 1 %: T, N; R23/24/25-50/53

0,25 % ≤ C < 1 %: Xn, N; R20/21/22-50/53

0,025 % ≤ C < 0,25 %: N; R51/53

0,0025 % ≤ C < 0,025 %: R52/53

1

050-018-00-8

tin(II) methanesulphonate

 

401-640-7

53408-94-9

C; R34

Xn; R22

R43

N; R51-53

C; N

R: 22-34-43-51/53

S: (1/2-)22-26-36/37/39-45-61

 

 

053-003-00-4

iodoxybenzene

 

696-33-3

E; R2

E

R: 2

S: (2-)35

 

 

053-004-00-X

calcium iodoxybenzoate

C

E; R2

E

R: 2

S: (2-)35

 

 

080-001-00-0

mercury

E

231-106-7

7439-97-6

Repr. Cat. 2; R61

T+; R26

T; R48/23

N; R50-53

T+; N

R: 61-26-48/23-50/53

S: 53-45-60-61

 

 

080-010-00-X

mercury dichloride;

mercuric chloride

 

231-299-8

7487-94-7

Muta. Cat. 3; R68

Repr. Cat. 3; R62

T+; R28

T; R48/24/25

C; R34

N; R50-53

T+; N

R: 28-34-48/24/25-62-68-50/53

S: (1/2-)26-36/37/39-45-60-61

 

 

092-002-00-3

uranium compounds with the exception of those specified elsewhere in this Annex

A

T+; R26/28

R33

N; R51-53

T+; N

R: 26/28-33-51/53

S: (1/2-)20/21-45-61

 

 

601-065-00-3

A mixture of: (1′α,3′α,6′α)-2,2,3′,7′,7′-pentamethylspiro(1,3-dioxane-5,2′-norcarane);

(1′α,3′β,6′α)-2,2,3′,7′,7′-pentamethylspiro(1,3-dioxane-5,2′-norcarane)

 

416-930-9

Xi; R38

N; R51-53

Xi; N

R: 38-51/53

S: (2-)36/37-61

 

 

602-007-00-X

bromoform;

tribromomethane

 

200-854-6

75-25-2

T; R23

Xn; R22

Xi; R36/38

N; R51-53

T; N

R: 22-23-36/38-51/53

S: (1/2-)28-45-63-61

 

 

602-030-00-5

1,3-dichloropropene; [1]

(Z)-1,3-dichloropropene [2]

C D

208-826-5 [1]

233-195-8 [2]

542-75-6 [1]

10061-01-5 [2]

R10

T; R24/25

Xn; R20-65

Xi; R36/37/38

R43

N; R50-53

T; N

R: 10-20-24/25-36/37/38-43-65-50/53

S: (1/2-)36/37-45-60-61

 

 

602-054-00-6

3-iodpropene;

allyl iodide

 

209-130-4

556-56-9

F; R11

C; R34

F; C

R: 11-34

S: (1/2-)7-16-26-45

 

 

603-005-00-1

2-methylpropan-2-ol;

tert-butyl alcohol

 

200-889-7

75-65-0

F; R11

Xn; R20

Xi; R36/37

F; Xn

R: 11-20-36/37

S: (2-)9-16-46

 

 

603-018-00-2

furfuryl alcohol

 

202-626-1

98-00-0

Carc. Cat. 3; R40

T; R23

Xn; R21/22-48/20

Xi; R36/37

T

R: 21/22-23-36/37-40-48/20

S: (1/2-)36/37-45-63

 

 

603-023-00-X

ethylene oxide;

oxirane

E

200-849-9

75-21-8

F+; R12

R6

Carc. Cat. 2; R45

Muta. Cat. 2; R46

T; R23

Xi; R36/37/38

F+; T

R: 45-46-6-12-23-36/37/38

S: 53-45

 

 

603-029-00-2

bis(2-chloroethyl) ether

 

203-870-1

111-44-4

Carc. Cat. 3; R40

T+; R26/27/28

T+

R: 26/27/28-40

S: (1/2-)7/9-27-28-36/37-45

C ≥ 7 %: T+; R26/27/28-40

1 % ≤ C < 7 %: T; R23/24/25-40

0,1 % ≤ C < 1 %: Xn; R20/21/22

 

603-037-00-6

cellulose nitrate;

nitrocellulose

T

E; R3

E

R: 3

S: (2-)35

 

 

603-046-00-5

bis(chloromethyl) ether;

oxybis(chloromethane)

E

208-832-8

542-88-1

F; R11

Carc. Cat. 1; R45

T+; R26

T; R24

Xn; R22

F; T+

R: 45-11-22-24-26

S: 53-45

C ≥ 25 %: T+; R45-22-24-26

7 % ≤ C < 25 %: T+; R45-21-26

3 % ≤ C < 7 %: T; R45-21-23

1 % ≤ C < 3 %: T; R45-23

0,1 % ≤ C < 1 %: T; R45-20

0,001 % ≤ C < 0,1 %: T; R45

 

603-064-00-3

1-methoxy-2-propanol;

monopropylene glycol methyl ether

 

203-539-1

107-98-2

R10

R67

R: 10-67

S: (2-)

 

 

603-066-00-4

1,2-epoxy-4-epoxyethylcyclohexane;

4-vinylcyclohexene diepoxide

 

203-437-7

106-87-6

Carc. Cat. 3; R40

T; R23/24/25

T

R: 23/24/25-40

S: (1/2-)36/37-45-63

C ≥ 1 %: T; R23/24/25-40

0,1 % ≤ C < 1 %: Xn; R20/21/22

 

605-004-00-1

2,4,6-trimethyl-1,3,5-trioxane;

paraldehyde

 

204-639-8

123-63-7

R10

R: 10

S: (2-)29

 

 

605-005-00-7

2,4,6,8-tetramethyl-1,3,5,7-tetraoxacyclooctane;

metaldehyde

 

203-600-2

108-62-3

F; R11

Xn; R22

F; Xn

R: 11-22

S: (2-)13-16-25-46

 

 

606-021-00-7

N-methyl-2-pyrrolidone;

1-methyl-2-pyrrolidone

 

212-828-1

872-50-4

Repr. Cat. 2; R61

Xi; R36/37/38

T

R: 61-36/37/38

S: 53-45

C ≥ 10 %: T; R61-36/37/38

5 % ≤ C < 10 %: T; R61

 

607-007-00-3

salts of oxalic acid with the exception of those specified elsewhere in this Annex

A

Xn; R21/22

Xn

R: 21/22

S: (2-)24/25

C ≥ 5 %: Xn; R21/22

 

607-012-00-0

benzoyl chloride

 

202-710-8

98-88-4

Xn; R20/21/22

C; R34

R43

C

R: 20/21/22-34-43

S: (1/2-)26-36/37/39-45

 

 

607-037-00-7

2-ethoxyethyl acetate;

ethylglycol acetate

E

203-839-2

111-15-9

R10

Repr. Cat. 2; R60-61

Xn; R20/21/22

T

R: 60-61-10-20/21/22

S: 53-45

 

 

607-051-00-3

MCPA (ISO);

4-chloro-o-tolyloxyacetic acid

 

202-360-6

94-74-6

Xn; R22

Xi; R38-41

N; R50-53

Xn; N

R: 22-38-41-50/53

S: (2-)26-37-39-60-61

 

 

607-052-00-9

salts and esters of MCPA

A

Xn; R20/21/22

N; R50-53

Xn; N

R: 20/21/22-50/53

S: (2-)13-60-61

 

 

607-085-00-9

benzyl benzoate

 

204-402-9

120-51-4

Xn; R22

N; R51-53

Xn; N

R: 22-51/53

S: (2-)25-46-61

 

 

607-095-00-3

maleic acid

 

203-742-5

110-16-7

Xn; R22

Xi; R36/37/38

R43

Xn

R: 22-36/37/38-43

S: (2-)24-26-28-37-46

C ≥ 25 %: Xn; R22-36/37/38-43

20 % ≤ C <25 %: Xi; R36/37/38-43

0,1 % ≤ C < 20 %: Xi; R43

 

607-103-00-5

succinic anhydride

 

203-570-0

108-30-5

Xn; R22

Xi; R36/37

Xn

R: 22-36/37

S: (2-)25-46

C ≥ 5 %: Xn; R22-36/37

1 % ≤ C < 5 %: Xi; R36/37

 

607-142-00-8

propyl chloroformate;

chloroformic acid propylester;

n-propyl chloroformate

 

203-687-7

109-61-5

F; R11

T; R23

C; R34

F; T

R: 11-23-34

S: (1/2-)16-26-36-45

 

 

607-195-00-7

2-methoxy-1-methylethyl acetate

 

203-603-9

108-65-6

R10

R: 10

S: (2-)

 

 

607-216-00-X

glutamic acid, reaction products with N-(C12-14-alkyl)propylenediamine

 

403-950-8

T+; R26

Xn; R22

C; R34

N; R50

T+; N

R: 22-26-34-50

S: (1/2-)26-36/37/39-38-45-61

 

 

607-231-00-1

clopyralid (ISO);

3,6-dichloropyridine-2-carboxylic acid

 

216-935-4

1702-17-6

Xi; R41

Xi

R: 41

S: (2-)26-39

 

 

607-245-00-8

tert-butyl acrylate

D

216-768-7

1663-39-4

F; R11

Xn; R20/21/22

Xi; R37/38

R43

N; R51-53

F; Xn; N

R: 11-20/21/22-37/38-43-51/53

S: (2-)16-25-37-61

C ≥ 25 %: Xn; R20/21/22-37/38-43-51/53

20 % ≤ C < 25 %: Xi; R37/38-43-52/53

2,5 % ≤ C < 20 %: Xi; R43-52/53

1 % ≤ C < 2,5 %: Xi; R43

 

607-397-00-5

A mixture of: Ca salicylates (branched C10-14 and C18-30 alkylated);

Ca phenates (branched C10-14 and C18-30 alkylated);

Ca sulfurised phenates (branched C10-14 and C18-30 alkylated)

 

415-930-6

Repr. Cat. 3; R62

R43

Xn

R: 43-62

S: (2-)23-36/37

 

 

608-005-00-5

n-butyronitrile

 

203-700-6

109-74-0

F; R11

T; R23/24/25

F; T

R: 11-23/24/25

S: (1/2-)16-36/37-45-63

 

 

608-011-00-8

oxalonitrile;

cyanogen

 

207-306-5

460-19-5

F+; R12

T; R23

N; R50-53

F+; T; N

R: 12-23-50/53

S: (1/2-)9-16-23-33-45-63-60-61

 

 

608-044-00-8

2-cyclohexylidene-2-phenylacetonitrile

 

423-740-1

10461-98-0

Xn; R22

N; R51-53

Xn; N

R; 22-51/53

S: (2-)46-61

 

 

609-007-00-9

2,4-dinitrotoluene; [1]

dinitrotoluene [2]

E

204-450-0 [1]

246-836-1 [2]

121-14-2 [1]

25321-14-6 [2]

Carc. Cat. 2; R45

Muta. Cat. 3; R68

Repr. Cat. 3; R62

T; R23/24/25

Xn; R48/22

N; R50-53

T; N

R: 45-23/24/25-48/22-62-68-50/53

S: 53-45-60-61

 

 

611-028-00-3

C,C′-azodi(formamide)

 

204-650-8

123-77-3

E; R2

R42

E; Xn

R: 2-42

S: (2-)22-24-37

 

 

611-035-00-1

tetralithium 6-amino-4-hydroxy-3-[7-sulfonato-4-(5-sulfonato-2-naphthylazo)-1-naphthylazo]naphthalene-2,7-disulfonate

 

403-660-1

107246-80-0

N; R51-53

N

R: 51/53

S: 61

 

 

612-044-00-3

N,N′-diacetylbenzidine

E

210-338-2

613-35-4

Carc. Cat. 2; R45

Muta. Cat. 3; R68

Xn; R20/21/22

T

R: 45-20/21/22-68

S: 53-45

 

 

612-050-00-6

cyclohexylamine

 

203-629-0

108-91-8

R10

Repr. Cat. 3; R62

Xn; R21/22

C; R34

C

R: 10-21/22-34-62

S: (1/2-)26-36/37/39-45

C ≥ 25 %: C; R21/22-34-62

10 % ≤ C < 25 %: C; R34-62

5 % ≤ C < 10 %: Xn; R36/38-62

2 % ≤ C < 5 %: Xi; R36/38

 

612-076-00-8

ethyldimethylamine

 

209-940-8

598-56-1

F; R11

Xn; R20/22

C; R34

F; C

R: 11-20/22-34

S: (1/2-)3-16-26-36-45

 

 

612-099-00-3

4-methyl-m-phenylenediamine;

2,4-toluenediamine

E

202-453-1

95-80-7

Carc. Cat. 2; R45

Muta. Cat. 3; R68

Repr. Cat. 3; R62

T; R25

Xn; R21-48/22

R43

N; R51-53

T; N

R: 45-21-25-43-48/22-62-68-51/53

S: 53-45-61

 

 

612-101-00-2

methenamine;

hexamethylenetetramine

 

202-905-8

100-97-0

F; R11

R43

F; Xi

R: 11-43

S: (2-)24-37

 

 

612-151-00-5

methyl-phenylene diamine;

diaminotoluene;

[technical product - mixture of 4-methyl-m-phenylene diamine (EC No 202-453-1) and 2-methyl-m-phenylene diamine (EC No 212-513-9)]

E

Carc. Cat. 2; R45

Muta. Cat. 3; R68

Repr. Cat. 3; R62

T; R25

Xn; R21-48/22

Xi; R36

R43

N; R51-53

T; N

R: 45-21-25-36-43-48/22-62-68-51/53

S: 53-45-61

 

 

612-237-00-2

hydroxylammonium hydrogensulfate;

hydroxylamine sulfate(1:1); [1]

hydroxylamine phosphate; [2]

hydroxylamine dihydrogenphosphate; [3]

hydroxylamine 4-methylbenzenesulfonate [4]

T

233-154-4 [1]

244-077-0 [2]

242-818-2 [3]

258-872-5 [4]

10046-00-1 [1]

20845-01-6 [2]

19098-16-9 [3]

53933-48-5 [4]

E; R2

Carc. Cat. 3; R40

Xn; R21/22-48/22

Xi; R36/38

R43

N; R50

E; Xn; N

R: 21/22-36/38-40-43-48/22-50

S: (2-)36/37-61

 

 

613-116-00-7

tolylfluanid (ISO);

dichloro-N-[(dimethylamino)sulphonyl]fluoro-N-(p-tolyl)methanesulphenamide;

[containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]

 

211-986-9

731-27-1

T+; R26

T; R48/23

Xi; R36/37/38

R43

N; R50

T+; N

R: 26-36/37/38-43-48/23-50

S: (1/2-)28-36/37/39-45-63-61

C ≥ 20 %: T+, N; R26-36/37/38-43-48/23-50

10 % ≤ C < 20 %: T+, N; R26-43-48/23-50

7 % ≤ C < 10 %: T+, N; R26-43-48/20-50

2,5 % ≤ C < 7 %: T, N; R23-43-48/20-50

1 % ≤ C < 2,5 %: T; R23-43-48/20

0,1 % ≤ C < 1 %: Xn; R20

 

615-001-00-7

methyl isocyanate

 

210-866-3

624-83-9

F; R11

Repr. Cat. 3; R63

T+; R26

T; R24/25

R42/43

Xi; R37/38-41

F; T+

R: 11-24/25-26-37/38-41-42/43-63

S: (1/2-)16-26-27/28-36/37/39-45-63

 

 

615-004-00-3

salts of thiocyanic acid, with the exception of those specified elsewhere in this Annex

A

Xn; R20/21/22

R32

R52-53

Xn

R: 20/21/22-32-52/53

S: (2-)13-36/37-46-61

 

 

615-028-00-4

ethyl 2-(isocyanatosulfonyl)benzoate

 

410-220-2

77375-79-2

R14

Xn; R22-48/22

Xi; R41

R42/43

Xn

R: 14-22-41-42/43-48/22

S: (2-)8-23-26-30-35-36/37/39

 

 

615-030-00-5

alkali salts and alkali earth salts of thiocyanic acid, with the exception of those specified elsewhere in this Annex

A

Xn; R20/21/22

R32

R52-53

Xn

R: 20/21/22-32-52/53

S: (2-)13-36/37-46-61

 

 

615-031-00-0

thallium thiocyanate

 

222-571-7

3535-84-0

T+; R26/28

Xn; R21

R32

R33

N; R51-53

T+; N

R: 21-26/28-32-33-51/53

S: (1/2-)13-28-36/37-45-61

 

 

615-032-00-6

metal salts of thiocyanic acid, with the exception of those specified elsewhere in this Annex

A

Xn; R20/21/22

R32

N; R50-53

Xn; N

R: 20/21/22-32-50/53

S: (2-)13-36/37-46-60-61

 

 

616-124-00-9

lithium bis(trifluoromethylsulfonyl)imide

 

415-300-0

90076-65-6

T; R24/25

Xn; R48/22

C; R34

R52-53

T

R: 24/25-34-48/22-52/53

S: (1/2-)22-26-36/37/39-45-61

 

 

617-017-00-X

A mixture of: 2,2′-bis(tert-pentylperoxy)-p-diisopropylbenzene;

2,2′-bis(tert-pentylperoxy)-m-diisopropylbenzene

T

412-140-3

32144-25-5

E; R2

O; R7

R53

E

R: 2-7-53

S: (2-)3/7-14-36/37/39-61

 

 

650-016-00-2

Mineral wool, with the exception of those specified elsewhere in this Annex;

[Man-made vitreous (silicate) fibres with random orientation with alkaline oxide and alkali earth oxide (Na2O+K2O+CaO+MgO+BaO) content greater than 18 % by weight]

AQR

Carc. Cat. 3; R40

Xn

R: 40

S: (2-)36/37

 

 

650-017-00-8

Refractory Ceramic Fibres, Special Purpose Fibres, with the exception of those specified elsewhere in this Annex;

[Man-made vitreous (silicate) fibres with random orientation with alkaline oxide and alkali earth oxide (Na2O+K2O+CaO+ MgO+BaO) content less or equal to 18 % by weight]

AR

Carc. Cat. 2; R49

T

R: 49

S: 53-45

 

 


ANNEX 1B

Index No

Chemical name

Notes related to substances

EC No

CAS No

Classification

Labelling

Concentration Limits

Notes related to preparations

003-003-00-5

(2-methylpropyl)lithium;

isobutyllithium

 

440-620-2

920-36-5

F; R15-17

R14

C; R35

R67

N; R50-53

F; C; N

R: 14/15-17-35-67-50/53

S: (1/2-)6-16-26-30-33-36/37/39-43-45-60-61

 

 

005-013-00-5

diethylmethoxyborane

 

425-380-9

7397-46-8

F; R17

Xn; R20/21/22-48/22

C; R34

R43

R53

F; C

R: 17-20/21/22-34-43-48/22-53

S: (1/2-)6-26-36/37/39-43-45-61

 

 

005-014-00-0

4-formylphenylboronic acid

 

438-670-5

87199-17-5

R43

Xi

R: 43

S: (2-)24-37

 

 

005-017-00-7

sodium perborate; [1]

perboric acid, sodium salt; [2]

perboric acid, sodium salt, monohydrate; [3]

sodium peroxometaborate; [4]

perboric acid (HBO(O2)), sodium salt, monohydrate; [5]

sodium peroxoborate;

[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]

E

239-172-9 [1]

234-390-0 [2]

- [3]

231-556-4 [4]

- [5]

15120-21-5 [1]

11138-47-9 [2]

12040-72-1 [3]

7632-04-4 [4]

10332-33-9 [5]

O; R8

Repr. Cat. 2; R61

Repr. Cat. 3; R62

Xn; R22

Xi; R37-41

O; T

R: 61-8-22-37-41-62

S: 53-45

C ≥ 25 %: T; R61-22-37-41-62

22 % ≤ C < 25 %: T; R61-37-41-62

20 % ≤ C < 22 %: T; R61-36/37-62

14 % ≤ C < 20 %: T; R61-36-62

9 % ≤ C < 14 %: T; R61-62

6,5 % ≤ C < 9 %: T; R61

 

005-017-01-4

sodium perborate; [1]

perboric acid, sodium salt; [2]

perboric acid, sodium salt, monohydrate; [3]

sodium peroxometaborate; [4]

perboric acid (HBO(O2)), sodium salt, monohydrate; [5]

sodium peroxoborate;

[containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]

E

239-172-9 [1]

234-390-0 [2]

- [3]

231-556-4 [4]

- [5]

15120-21-5 [1]

11138-47-9 [2]

12040-72-1 [3]

7632-04-4 [4]

10332-33-9 [5]

O; R8

Repr. Cat. 2; R61

Repr. Cat. 3; R62

T; R23

Xn; R22

Xi; R37-41

O; T

R: 61-8-22-23-37-41-62

S: 53-45

C ≥ 25 %: T; R61-22-23-37-41-62

22 % ≤ C < 25 %: T; R61-20-37-41-62

20 % ≤ C < 22 %: T; R61-20-36/37-62

14 % ≤ C < 20 %: T; R61-20-36-62

9 % ≤ C < 14 %: T; R61-20-62

6,5 % ≤ C < 9 %: T; R61-20

3 % ≤ C < 6,5 %: Xn; R20

 

005-018-00-2

perboric acid (H3BO2(O2)), monosodium salt trihydrate; [1]

perboric acid, sodium salt, tetrahydrate; [2]

perboric acid (HBO(O2)), sodium salt, tetrahydrate; [3]

sodium peroxoborate hexahydrate;

[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]

 

- [1]

- [2]

- [3]

13517-20-9 [1]

37244-98-7 [2]

10486-00-7 [3]

Repr. Cat. 2; R61

Repr. Cat. 3; R62

Xi; R37-41

T

R: 61-37-41-62

S: 53-45-47

C ≥ 36 %: T; R61-37-41-62

22 % ≤ C < 36 %: T; R61-36/37-62

20 % ≤ C < 22 %: T; R61-37-62

14 % ≤ C < 20 %: T; R61-62

10 % ≤ C < 14 %: T; R61

 

005-018-01-X

perboric acid (H3BO2(O2)), monosodium salt, trihydrate; [1]

perboric acid, sodium salt, tetrahydrate; [2]

perboric acid (HBO(O2)), sodium salt, tetrahydrate; [3]

sodium peroxoborate hexahydrate;

[containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]

E

- [1]

- [2]

- [3]

13517-20-9 [1]

37244-98-7 [2]

10486-00-7 [3]

Repr. Cat. 2; R61

Repr. Cat. 3; R62

Xn; R20

Xi; R37-41

T

R: 61-20-37-41-62

S: 53-45-47

C ≥ 36 %: T; R61-20-37-41-62

25 % ≤ C < 36 %: T; R61-20-36/37-62

22 % ≤ C < 25 %: T; R61-36/37-62

20 % ≤ C < 22 %: T; R61-37-62

14 % ≤ C < 20 %: T; R61-62

10 % ≤ C < 14 %: T; R61

 

006-097-00-6

1-phenyl-3-(p-toluenesulfonyl)urea

 

424-620-1

13909-63-2

Xn; R22-48/22

R52-53

Xn

R: 22-48/22-52/53

S: (2-)22-36-61

 

 

006-098-00-1

tert-butyl (1R,5S)-3-azabicyclo[3.1.0]hex-6-ylcarbamate

 

429-170-8

134575-17-0

Xn; R22-48/22

Xi; R41

R43

Xn

R: 22-41-43-48/22

S: (2-)22-26-36/37/39

 

 

006-099-00-7

N-(p-toluenesulfonyl)-N′-(3-(p-toluenesulfonyloxy)phenyl)urea;

3-({[(4-methylphenyl)sulfonyl]carbamoyl}amino)phenyl 4-methylbenzenesulfonate

 

432-520-2

232938-43-1

N; R51-53

N

R: 51/53

S: 22-61

 

 

006-101-00-6

mixture of: N,N″-(methylenedi-4,1-phenylene)bis[N′-phenylurea];

N-(4-[[4-[[(phenylamino)carbonyl]amino]phenylmethyl]phenyl]-N′-cyclohexylurea;

N,N″-(methylenedi-4,1-phenylene)bis[N′-cyclohexylurea]

 

423-070-8

R53

R: 53

S: 61

 

 

006-102-00-1

O-hexyl-N-ethoxycarbonylthiocarbamate

E

432-750-3

Carc. Cat. 2; R45

Muta. Cat. 2; R46

Xn; R22-48/22

R43

N; R51-53

T; N

R: 45-46-22-43-48/22-51/53

S: 53-45-61

 

 

006-103-00-7

N,N″-(methylenedi-4,1-phenylene)bis[N′-octyl]urea

 

445-760-8

Xi; R41

R42

N; R50-53

Xn; N

R: 41-42-50/53

S: (2-)22-26-39-45-60-61

C ≥10 %: Xn, N; R41-42-50/53

5 % ≤ C < 10 %: Xn, N; R36-42-50/53

1 % ≤ C < 5 %: Xn, N; R42-50/53

0,25 % ≤ C < 1 %: N; R50/53

0,025 % ≤ C < 0,25 %: N; R51/53

0,0025 ≤ C < 0,025 %: R52/53

 

007-029-00-8

diethyldimethylammonium hydroxide

 

419-400-5

95500-19-9

Xn; R21/22

C; R35

C

R: 21/22-35

S: (1/2-)26-36/37/39-45

 

 

012-004-00-X

aluminium-magnesium-carbonate-hydroxide-perchlorate-hydrate

 

422-150-1

N; R50-53

N

R: 50/53

S: 60-61

 

 

014-036-00-X

(4-ethoxyphenyl)(3-(4-fluoro-3-phenoxyphenyl)propyl)dimethylsilane

 

405-020-7

105024-66-6

Repr.Cat.2; R60

N; R50-53

T; N

R: 60-50/53

S: 53-45-60-61

C ≥ 0,5 %: T, N; R60-50/53

0,025 % ≤ C < 0,5 %: N; R50/53

0,0025 % ≤ C < 0,025 %: N; R51/53

0,00025 % ≤ C < 0,0025 %: R52/53

 

014-037-00-5

2-butanone-O,O′,O′′-(phenylsilylidyne)trioxime

 

433-360-6

34036-80-1

Xn; R48/22

R43

R52-53

Xn

R: 43-48/22-52/53

S: (2-)36/37-61

 

 

014-038-00-0

S-(3-(triethoxysilyl)propyl)octanethioate

 

436-690-9

220727-26-4

R43

Xi

R: 43

S: (2-)24-37

 

 

014-039-00-6

(2,3-dimethylbut-2-yl)-trimethoxysilane

 

439-360-2

142877-45-0

Xi; R38-41

R52-53

Xi

R: 38-41-52/53

S: (2-)26-37/39-61

 

 

014-041-00-7

N,N-bis(trimethylsilyl)aminopropylmethyldiethoxysilane

 

445-890-5

201290-01-9

Xn; R22

R43

Xn

R: 22-43

S: (2-)24-37

 

 

014-042-00-2

mixture of: O,O′,O″,O′′′-silanetetrayl tetrakis(4-methyl-2-pentanone oxime) (3 stereoisomers)

 

423-010-0

Xi; R41

Xi

R: 41

S: (2-)26-39

 

 

014-043-00-8

reaction product of amorphous silica (50-85 %), butyl (1-methylpropyl) magnesium (3-15 %), tetraethyl orthosilicate (5-15 %) and titanium tetrachloride (5-20 %)

 

432-200-2

F; R11

Xi; R37/38-41

R52-53

F; Xi

R: 11-37/38-41-52/53

S: (2-)6-26-36/39-61

 

 

014-044-00-3

3-[(4′-acetoxy-3′-methoxyphenyl) propyl]trimethoxysilane

 

433-050-0

N; R51-53

N

R: 51/53

S: 61

 

 

014-045-00-9

magnesium sodium fluoride silicate

 

442-650-1

Xn; R48/20

Xn

R: 48/20

S: (2-)22-36

 

 

015-190-00-0

bis(2,4-dicumylphenyl) neopentyl diphosphite;

3,9-bis[2,4-bis(1-methyl-1-phenylethyl)phenoxy]-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane

 

421-920-2

154862-43-8

R53

R: 53

S: 61

 

 

015-191-00-6

dodecyldiphenyl phosphate

 

431-760-5

27460-02-2

Xi; R38

R52-53

Xi

R: 38-52/53

S: (2-)37-61

 

 

015-192-00-1

tetrakis(2,6-dimethylphenyl)-m-phenylene biphosphate

 

432-770-2

139189-30-3

R43

R53

Xi

R: 43-53

S: (2-)24-37-61

 

 

015-193-00-7

triphenyl(phenylmethyl)phosphonium 1,1,2,2,3,3,4,4,4-nonafluoro-N-methyl-1-butanesulfonamide (1:1)

 

442-960-7

332350-93-3

T; R25

Xi; R41

N; R50-53

T; N

R: 25-41-50/53

S: (1/2-)26-39-45-60-61

 

 

015-194-00-2

tetrabutyl-phosphonium nonafluoro-butane-1-sulfonate

 

444-440-5

220689-12-3

Xn; R22

R52-53

Xn

R: 22-52/53

S: (2-)61

 

 

015-195-00-8

mixture of: potassium o-toluenephosphonate;

potassium m-toluenephosphonate;

potassium p-toluenephosphonate

 

433-860-4

Xi; R36

R43

R52-53

Xi

R: 36-43-52/53

S: (2-)24-26-37-61

 

 

015-196-00-3

mixture of: dimethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate;

diethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate;

methyl ethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate

 

435-960-3

Carc.Cat.2; R45

Muta.Cat.2; R46

R43

T

R: 45-46-43

S: 53-45

 

 

015-197-00-9

bis(2,4,4-trimethylpentyl)dithiophosphonic acid

 

420-160-9

107667-02-7

R10

T; R23

Xn; R22

C; R34

N; R51-53

T; N

R: 10-22-23-34-51/53

S: (1/2-)9-26-36/37/39-45-61

 

 

015-198-00-4

(4-phenylbutyl)phosphinic acid

 

420-450-5

86552-32-1

Carc.Cat.3; R40

Xi; R41

Xn

R: 40-41

S: (2-)23-26-36/37/39

 

 

016-094-00-1

sulfur

 

231-722-6

7704-34-9

Xi; R38

Xi

R: 38

S: (2-)46

 

 

016-097-00-8

1-amino-2-methyl-2-propanethiol hydrochloride

 

434-480-1

32047-53-3

Xn; R22

C; R34

R43

R52-53

C

R: 22-34-43-52/53

S: (1/2-)22-26-36/37/39-45-61

 

 

017-009-01-8

ammonium perchlorate;

[containing < 80 % of 0-30 μm particles]

T

232-235-1

7790-98-9

E; R2

O; R9

E

R: 2-9

S: (2-)14-16-36/37

 

 

022-004-00-1

potassium titanium oxide (K2Ti6O13)

 

432-240-0

12056-51-8

Carc.Cat.3; R40

Xn

R: 40

S: (2-)22-36/37

 

 

022-005-00-7

[N-(1,1-dimethylethyl)-1,1-dimethyl-1-[(1,2,3,4,5-η)-2,3,4,5-tetramethyl-2,4-cyclopentadien-1-yl]silanaminato(2-)-κN][(1,2,3,4-η)-1,3-pentadiene]-titanium

 

419-840-8

169104-71-6

F; R11

C; R34

R43

R53

F; C

R: 11-34-43-53

S: (1/2-)6-9-16-26-36/37/39-45-61

 

 

028-002-01-4

nickel powder;

[particle diameter < 1 mm]

 

231-111-4

7440-02-0

Carc. Cat. 3; R40

T; R48/23

R43

R52-53

T

R: 40-43-48/23-52/53

S: (2-)36/37/39-45-61

 

 

028-013-00-7

nickel matte

E, H

273-749-6

69012-50-6

Carc. Cat. 1; R49

T; R48/23

R43

N; R50-53

T; N

R: 49-43-48/23-50/53

S: 53-45-60-61

 

 

028-014-00-2

slimes and sludges, copper electrolytic refining, decopperised, nickel sulfate

E

295-859-3

92129-57-2

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

Xn; R20/22

Xi; R38

R42/43

N; R50-53

T; N

R: 49-61-20/22-38-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-20/22-38-42/43-48/23-68-50/53

20 % ≤ C < 25 %: T, N; R49-61-38-42/43-48/23-68-51/53

2,5 % ≤ C < 20 %: T, N; R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

 

028-015-00-8

slimes and sludges, copper electrolyte refining, decopperised

E, H

305-433-1

94551-87-8

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 1; R61

Repr. Cat. 3; R62

T; R48/23

R42/43

N; R50-53

T; N

R: 49-61-42/43-48/23-62-68-50/53

S: 53-45-60-61

 

 

028-016-00-3

nickel diperchlorate;

perchloric acid, nickel(II) salt

E, H

237-124-1

13637-71-3

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

C; R34

R42/43

N; R50-53

T; N

R: 49-61-34-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-34-42/43-48/23-68-50/53

5 % ≤ C < 25 %: T, N; R49-61-34-42/43-48/23-68-51/53

2,5 % ≤ C < 5 %: T, N; R49-61-36/38-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-36/38-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

 

028-017-00-9

nickel dipotassium bis(sulfate); [1]

diammonium nickel bis(sulfate) [2]

E, H

237-563-9 [1]

239-793-2 [2]

13842-46-1 [1]

15699-18-0 [2]

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

Xn; R20/22

R42/43

N; R50-53

T; N

R: 49-61-20/22-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-20/22-42/43-48/23-68-50/53

2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

 

028-018-00-4

nickel bis(sulfamidate);

nickel sulfamate

E, H

237-396-1

13770-89-3

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

R42/43

N; R50-53

T; N

R: 49-61-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53

2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

 

028-019-00-X

nickel bis(tetrafluoroborate)

E, H

238-753-4

14708-14-6

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

R42/43

N; R50-53

T; N

R: 49-61-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53

2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; 49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

 

028-021-00-0

nickel diformate; [1]

formic acid, nickel salt; [2]

formic acid, copper nickel salt [3]

E, H

222-101-0 [1]

239-946-6 [2]

268-755-0 [3]

3349-06-2 [1]

15843-02-4 [2]

68134-59-8 [3]

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

R42/43

N; R50-53

T; N

R: 49-61-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53

2,5 % C < 25 %: T, N; R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5%: T; R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C 0,1 %: Xi; R43

 

028-022-00-6

nickel di(acetate); [1]

nickel acetate [2]

E, H

206-761-7 [1]

239-086-1 [2]

373-02-4 [1]

14998-37-9 [2]

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

Xn; R20/22

R42/43

N; R50-53

T; N

R: 49-61-20/22-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-20/22-42/43-48/23-68-50/53

2,5 % ≤ C < 25 %: T, N: R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

 

028-024-00-7

nickel dibenzoate

E, H

209-046-8

553-71-9

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

R42/43

N; R50-53

T; N

R: 49-61-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53

2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

 

028-025-00-2

nickel bis(4-cyclohexylbutyrate)

E, H

223-463-2

3906-55-6

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

R42/43

N; R50-53

T; N

R: 49-61-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53

2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

 

028-026-00-8

nickel(II) stearate;

nickel(II) octadecanoate

E, H

218-744-1

2223-95-2

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

R42/43

N; R50-53

T; N

R: 49-61-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53

2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

 

028-027-00-3

nickel dilactate

E, H

16039-61-5

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

R42/43

N; R50-53

T; N

R: 49-61-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53

2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

 

028-028-00-9

nickel(II) octanoate

E, H

225-656-7

4995-91-9

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat 2; R61

T; R48/23

C; R35

R42/43

N; R50-53

T; C; N

R: 49-61-35-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, C, N; R49-61-35-42/43-48/23-68-50/53

10 % ≤ C < 25 %: T, C, N; R49-61-35-42/43-48/23-68-51/53

5 % ≤ C < 10 %: T, N; R49-61-34-42/43-48/23-68-51/53

2,5 % ≤ C < 5 %: T, N; R49-61-36/38-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-36/38-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

 

028-029-00-4

nickel difluoride; [1]

nickel dibromide; [2]

nickel diiodide; [3]

nickel potassium fluoride [4]

E, H

233-071-3 [1]

236-665-0 [2]

236-666-6 [3]

- [4]

10028-18-9 [1]

13462-88-9 [2]

13462-90-3 [3]

11132-10-8 [4]

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

R42/43

N; R50-53

T; N

R: 49-61-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53

2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; 49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; 49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

 

028-030-00-X

nickel hexafluorosilicate

E, H

247-430-7

26043-11-8

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

R42/43

N; R50-53

T; N

R: 49-61-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53

2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

 

028-031-00-5

nickel selenate

E, H

239-125-2

15060-62-5

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

R42/43

N; R50-53

T; N

R: 49-61-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53

2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

 

028-032-00-0

nickel hydrogen phosphate; [1]

nickel bis(dihydrogen phosphate); [2]

trinickel bis(orthophosphate); [3]

dinickel diphosphate; [4]

nickel bis(phosphinate); [5]

nickel phosphinate; [6]

phosphoric acid, calcium nickel salt; [7]

diphosphoric acid, nickel(II) salt [8]

E, H

238-278-2 [1]

242-522-3 [2]

233-844-5 [3]

238-426-6 [4]

238-511-8 [5]

252-840-4 [6]

- [7]

- [8]

14332-34-4 [1]

18718-11-1 [2]

10381-36-9 [3]

14448-18-1 [4]

14507-36-9 [5]

36026-88-7 [6]

17169-61-8 [7]

19372-20-4 [8]

Carc. Cat. 1; R49

T; R48/23

R42/43

N; R50-53

T; N

R: 49-42/43-48/23-50/53

S: 53-45-60-61

 

 

028-033-00-6

diammonium nickel hexacyanoferrate

E, H

74195-78-1

Carc. Cat. 1; R49

T; R48/23

R42/43

N; R50-53

T; N

R: 49-42/43-48/23-50/53

S: 53-45-60-61

 

 

028-034-00-1

nickel dicyanide

E, H

209-160-8

557-19-7

Carc. Cat. 1; R49

T; R48/23

R42/43

R32

N; R50-53

T; N

R: 49-32-42/43-48/23-50/53

S: 53-45-60-61

 

 

028-035-00-7

nickel chromate

E, H

238-766-5

14721-18-7

Carc. Cat. 1; R49

T; R48/23

R42/43

N; R50-53

T; N

R: 49-42/43-48/23-50/53

S: 53-45-60-61

 

 

028-036-00-2

nickel(II) silicate; [1]

dinickel orthosilicate; [2]

nickel silicate (3:4); [3]

silicic acid, nickel salt; [4]

trihydrogen hydroxybis[orthosilicato(4-)]trinickelate(3-) [5]

E, H

244-578-4 [1]

237-411-1 [2]

250-788-7 [3]

253-461-7 [4]

235-688-3 [5]

21784-78-1 [1]

13775-54-7 [2]

31748-25-1 [3]

37321-15-6 [4]

12519-85-6 [5]

Carc. Cat. 1; R49

T; R48/23

R43

N; R50-53

T; N

R: 49-43-48/23-50/53

S: 53-45-60-61

 

 

028-037-00-8

dinickel hexacyanoferrate

E, H

238-946-3

14874-78-3

Carc. Cat. 1; R49

T; R48/23

R43

N; R50-53

T; N

R: 49-43-48/23-50/53

S: 53-45-60-61

 

 

028-038-00-3

trinickel bis(arsenate);

nickel(II) arsenate

E, H

236-771-7

13477-70-8

Carc. Cat. 1; R45

T; R48/23

R43

N; R50-53

T; N

R: 45-43-48/23-50/53

S: 53-45-60-61

 

 

028-039-00-9

nickel oxalate; [1]

oxalic acid, nickel salt [2]

E, H

208-933-7 [1]

243-867-2 [2]

547-67-1 [1]

20543-06-0 [2]

Carc. Cat. 1; R49

T; R48/23

R43

N: R50-53

T; N

R: 49-43-48/23-50/53

S: 53-45-60-61

 

 

028-040-00-4

nickel telluride

E, H

235-260-6

12142-88-0

Carc. Cat. 1; R49

T; R48/23

R43

N; R50-53

T; N

R: 49-43-48/23-50/53

S: 53-45-60-61

 

 

028-041-00-X

trinickel tetrasulfide

E, H

12137-12-1

Carc. Cat. 1; R49

T; R48/23

R43

N; R50-53

T; N

R: 49-43-48/23-50/53

S: 53-45-60-61

 

 

028-042-00-5

trinickel bis(arsenite)

E, H

74646-29-0

Carc. Cat. 1; R49

T; R48/23

R43

N; R50-53

T; N

R: 49-43-48/23-50/53

S: 53-45-60-61

 

 

028-043-00-0

cobalt nickel gray periclase;

C.I. Pigment Black 25;

C.I. 77332; [1]

cobalt nickel dioxide; [2]

cobalt nickel oxide [3]

E, H

269-051-6 [1]

261-346-8 [2]

- [3]

68186-89-0 [1]

58591-45-0 [2]

12737-30-3 [3]

Carc. Cat. 1; R49

T; R48/23

R43

T

R: 49-43-48/23

S: 53-45

 

 

028-044-00-6

nickel tin trioxide;

nickel stannate

E, H

234-824-9

12035-38-0

Carc. Cat. 1; R49

T; R48/23

R43

T

R: 49-43-48/23

S: 53-45

 

 

028-045-00-1

nickel triuranium decaoxide

E, H

239-876-6

15780-33-3

Carc. Cat. 1; R49

T; R48/23

R43

T

R: 49-43-48/23

S: 53-45

 

 

028-046-00-7

nickel dithiocyanate

E, H

237-205-1

13689-92-4

Carc. Cat. 1; R49

Muta. Cat. 3;R68

Repr. Cat. 2; R61

T; R48/23

R42/43

R32

N; R50-53

T; N

R: 49-61-32-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53

2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T: R49-61-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

 

028-047-00-2

nickel dichromate

E, H

239-646-5

15586-38-6

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

R42/43

N; R50-53

T; N

R: 49-61-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53

2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; 49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1% ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C 0,1 %: Xi; R43

 

028-048-00-8

nickel(II) selenite

E, H

233-263-7

10101-96-9

Carc. Cat. 1; R49

T; R48/23

R42/43

N; R50-53

T; N

R: 49-42/43-48/23-50/53

S: 53-45-60-61

 

 

028-049-00-3

nickel selenide

E, H

215-216-2

1314-05-2

Carc. Cat. 1; R49

T; R48/23

R43

N; R50-53

T; N

R: 49-43-48/23-50/53

S: 53-45-60-61

 

 

028-050-00-9

silicic acid, lead nickel salt

E, H

68130-19-8

Carc. Cat. 1: R49

Repr. Cat. 1: R61

Repr. Cat. 3; R62

T; R48/23

R43

N; R50-53

T; N

R: 49-61-43-48/23-62-50/53

S: 53-45-60-61

 

 

028-051-00-4

nickel diarsenide; [1]

nickel arsenide [2]

E, H

235-103-1 [1]

248-169-1 [2]

12068-61-0 [1]

27016-75-7 [2]

Carc. Cat. 1; R49

T; R48/23

R43

N; R50-53

T; N

R: 49-43-48/23-50/53

S: 53-45-60-61

 

 

028-052-00-X

nickel barium titanium primrose priderite;

C.I. Pigment Yellow 157;

C.I. 77900

E, H

271-853-6

68610-24-2

Carc. Cat. 1: R49

T; R48/23

R43

T

R: 49-43-48/23

S: 53-45

 

 

028-053-00-5

nickel dichlorate; [1]

nickel dibromate; [2]

ethyl hydrogen sulfate, nickel(II) salt [3]

E, H

267-897-0 [1]

238-596-1 [2]

275-897-7 [3]

67952-43-6 [1]

14550-87-9 [2]

71720-48-4 [3]

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

R42/43

N; R50-53

T; N

R: 49-61-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53

2,5 % ≤ C < 25 %: T, N: R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T: R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T: R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

 

028-054-00-0

nickel(II) trifluoroacetate; [1]

nickel(II) propionate; [2]

nickel bis(benzenesulfonate); [3]

nickel(II) hydrogen citrate; [4]

citric acid, ammonium nickel salt; [5]

citric acid, nickel salt; [6]

nickel bis(2-ethylhexanoate); [7]

2-ethylhexanoic acid, nickel salt; [8]

dimethylhexanoic acid nickel salt; [9]

nickel(II) isooctanoate; [10]

nickel isooctanoate; [11]

nickel bis(isononanoate); [12]

nickel(II) neononanoate; [13]

nickel(II) isodecanoate; [14]

nickel(II) neodecanoate; [15]

neodecanoic acid, nickel salt; [16]

nickel(II) neoundecanoate; [17]

bis(D-gluconato-O 1,O 2)nickel; [18]

nickel 3,5-bis(tert-butyl)-4-hydroxybenzoate (1:2); [19]

nickel(II) palmitate; [20]

(2-ethylhexanoato-O)(isononanoato-O)nickel; [21]

(isononanoato-O)(isooctanoato-O)nickel; [22]

(isooctanoato-O)(neodecanoato-O)nickel; [23]

(2-ethylhexanoato-O)(isodecanoato-O)nickel; [24]

(2-ethylhexanoato-O)(neodecanoato-O)nickel; [25]

(isodecanoato-O)(isooctanoato-O)nickel; [26]

(isodecanoato-O)(isononanoato-O)nickel; [27]

(isononanoato-O)(neodecanoato-O)nickel; [28]

fatty acids, C6-19-branched, nickel salts; [29]

fatty acids, C8-18 and C18-unsaturated, nickel salts; [30]

2,7-naphthalenedisulfonic acid, nickel(II) salt; [31]

E, H

240-235-8 [1]

222-102-6 [2]

254-642-3 [3]

242-533-3 [4]

242-161-1 [5]

245-119-0 [6]

224-699-9 [7]

231-480-1 [8]

301-323-2 [9]

249-555-2 [10]

248-585-3 [11]

284-349-6 [12]

300-094-6 [13]

287-468-1 [14]

287-469-7 [15]

257-447-1 [16]

300-093-0 [17]

276-205-6 [18]

258-051-1 [19]

237-138-8 [20]

287-470-2 [21]

287-471-8 [22]

284-347-5 [23]

284-351-7 [24]

285-698-7 [25]

285-909-2 [26]

284-348-0 [27]

287-592-6 [28]

294-302-1 [29]

283-972-0 [30]

- [31]

16083-14-0 [1]

3349-08-4 [2]

39819-65-3 [3]

18721-51-2 [4]

18283-82-4 [5]

22605-92-1 [6]

4454-16-4 [7]

7580-31-6 [8]

93983-68-7 [9]

29317-63-3 [10]

27637-46-3 [11]

84852-37-9 [12]

93920-10-6 [13]

85508-43-6 [14]

85508-44-7 [15]

51818-56-5 [16]

93920-09-3 [17]

71957-07-8 [18]

52625-25-9 [19]

13654-40-5 [20]

85508-45-8 [21]

85508-46-9 [22]

84852-35-7 [23]

84852-39-1 [24]

85135-77-9 [25]

85166-19-4 [26]

84852-36-8 [27]

85551-28-6 [28]

91697-41-5 [29]

84776-45-4 [30]

72319-19-8 [31]

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

R42/43

N; R50-53

T; N

R: 49-61-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53

2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

 

028-055-00-6

nickel(II) sulfite; [1]

nickel tellurium trioxide; [2]

nickel tellurium tetraoxide; [3]

molybdenum nickel hydroxide oxide phosphate [4]

E, H

231-827-7 [1]

239-967-0 [2]

239-974-9 [3]

268-585-7 [4]

7757-95-1 [1]

15851-52-2 [2]

15852-21-8 [3]

68130-36-9 [4]

Carc. Cat. 1; R49

T; R48/23

R42/43

N; R50-53

T; N

R: 49-42/43-48/23-50/53

S: 53-45-60-61

 

 

028-056-00-1

nickel boride (NiB); [1]

dinickel boride; [2]

trinickel boride; [3]

nickel boride; [4]

dinickel silicide; [5]

nickel disilicide; [6]

dinickel phosphide; [7]

nickel boron phosphide [8]

E, H

234-493-0 [1]

234-494-6 [2]

234-495-1 [3]

235-723-2 [4]

235-033-1 [5]

235-379-3 [6]

234-828-0 [7]

- [8]

12007-00-0 [1]

12007-01-1 [2]

12007-02-2 [3]

12619-90-8 [4]

12059-14-2 [5]

12201-89-7 [6]

12035-64-2 [7]

65229-23-4 [8]

Carc. Cat. 1; R49

T; R48/23

R43

N; R50-53

T; N

R: 49-43-48/23-50/53

S: 53-45-60-61

 

 

028-057-00-7

dialuminium nickel tetraoxide; [1]

nickel titanium trioxide; [2]

nickel titanium oxide; [3]

nickel divanadium hexaoxide; [4]

cobalt dimolybdenum nickel octaoxide; [5]

nickel zirkonium trioxide; [6]

molybdenum nickel tetraoxide; [7]

nickel tungsten tetraoxide; [8]

olivine, nickel green; [9]

lithium nickel dioxide; [10]

molybdenum nickel oxide; [11]

E, H

234-454-8 [1]

234-825-4 [2]

235-752-0 [3]

257-970-5 [4]

268-169-5 [5]

274-755-1 [6]

238-034-5 [7]

238-032-4 [8]

271-112-7 [9]

- [10]

- [11]

12004-35-2 [1]

12035-39-1 [2]

12653-76-8 [3]

52502-12-2 [4]

68016-03-5 [5]

70692-93-2 [6]

14177-55-0 [7]

14177-51-6 [8]

68515-84-4 [9]

12031-65-1 [10]

12673-58-4 [11]

Carc. Cat. 1; R49

T; R48/23

R43

T

R: 49-43-48/23

S: 53-45

 

 

028-058-00-2

cobalt lithium nickel oxide

E

442-750-5

Carc. Cat. 1; R49

T+; R26

T; R48/23

R43

N; R50-53

T+; N

R: 49-26-43-48/23-50/53

S: 53-45-60-61

 

 

029-014-00-5

mixture of: 2,2′-[[cis-1,2-cyclohexanediylbis(nitrilomethylidene)]bis[phenolate]](2-)N,N′,O,O′-copper complex;

2,2′-[[trans-1,2-cyclohexanediylbis(nitrilomethylidyne)]bis[phenolate]](2-)N,N′,O,O′-copper complex

 

419-610-7

171866-24-3

Xn; R48/22

N; R51-53

Xn; N

R: 48/22-51/53

S: (2-)22-36-61

 

 

030-012-00-1

aluminium-magnesium-zinc-carbonate-hydroxide

 

423-570-6

169314-88-9

R52-53

R: 52/53

S: 61

 

 

030-015-00-8

tetrazinc(2+)bis(hexacyanocobalt(3+))diacetate

 

440-060-9

N; R51-53

N

R: 51/53

S: 61

 

 

042-005-00-0

mixture of: mono- and di-glycerols of canola oil;

canola oil acid amide of branched 1,3-propanediamine,N-[3-(tridecyloxy)-propyl];

N,N-diorgano dithiocarbamate molybdenum complex

 

434-240-6

R43

N; R51-53

Xi; N

R: 43-51/53

S: (2-)24-37-61

 

 

050-023-00-5

mixture of: bis[(2-ethyl-1-oxohexyl)oxy]dioctyl stannane;

bis[((2-ethyl-1-oxohexyl)oxy)dioctylstannyl]oxide;

bis(1-phenyl-1,3-decanedionyl)dioctyl stannane;

((2-ethyl-1-oxohexyl)oxy)-(1-phenyl-1,3-decanedionyl)dioctyl stannane

 

422-920-5

Xn; R48/22

N; R50-53

Xn; N

R: 48/22-50/53

S: (2-)23-36-60-61

C ≥ 10 %: Xn, N; R48/22-50/53

2,5 % ≤ C < 10 %: N; R50/53

0,25 % ≤ C < 2,5 %: N; R51/53

0,025 % ≤ C < 0,25 %: R52/53

 

050-024-00-0

mixture of: tri-p-tolyltin hydroxide;

hexa-p-tolyl-distannoxane

 

432-230-6

T; R48/25

Xn; R22

Xi; R38-41

R43

N; R50-53

T; N

R: 22-38-41-43-48/25-50/53

S: (1/2-)22-26-36/37/39-45-60-61

 

 

064-001-00-8

gadolinium(III)sulfite trihydrate

 

456-900-2

51285-81-5

N; R51-53

N

R: 51/53

S: 61

 

 

078-011-00-5

hydroxydisulfito platinum(II) acid

 

423-310-1

61420-92-6

Xn; R22-48/20/21/22

C; R35

R42/43

R52-53

C

R: 22-35-42/43-48/20/21/22-52/53

S: (1/2-)23-24-26-28-36/37/39-45-61

 

 

078-012-00-0

platinum(IV) nitrate/nitric acid solution

 

432-400-1

C; R35

N; R50-53

C; N

R: 35-50/53

S: (1/2-)26-36/37/39-45-60-61

 

 

082-012-00-6

barium calcium cesium lead samarium strontium bromide chloride fluoride iodide europium doped

 

431-780-4

199876-46-5

Xn; R22-48/22

N; R51-53

Xn; N

R: 22-48/22-51/53

S: (2-)22-36-61

 

 

601-080-00-5

mixture of: sec-butylphenyl(phenyl)methane, mixed isomers;

1-(sec-butylphenyl(phenyl)-2-phenylethane, mixed isomers;

1-(sec-butylphenyl-1-phenylethane, mixed isomers

 

431-100-6

N; R50-53

N

R: 50/53

S: 60-61

 

 

601-081-00-0

cyclohexadeca-1,9-diene

 

431-730-1

4277-06-9

Xi; R38

R43

R53

Xi

R: 38-43-53

S: (2-)36/37-61

 

 

601-082-00-6

mixture of: endo-2-methyl-exo-3-methyl-exo-2-[(exo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptane;

exo-2-methyl-exo-3-methyl-endo-2-[(endo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptane

 

434-420-4

Xi; R38-41

N; R50-53

Xi; N

R: 38-41-50/53

S: (2-)23-26-37/39-57-60-61

 

 

601-083-00-1

5-endo-hexyl-bicyclo[2.2.1]hept-2-ene

 

435-000-3

22094-83-3

Xn; R65

Xi; R38

R53

Xn

R: 38-65-53

S: (2-)37-62-61

 

 

601-084-00-7

mixture of: 5-endo-butyl-bicyclo[2.2.1]hept-2-ene;

5-exo-butyl-bicyclo[2.2.1]hept-2-ene (80:20)

 

435-180-3

Xn; R65

Xi; R38

N; R50-53

Xn; N

R: 38-65-50/53

S: (2-)37-62-60-61

 

 

602-105-00-2

sodium 1,1,2,2,3,3,4,4,4-nonafluoro-1-butanesulfinate

 

422-100-7

102061-82-5

Xi; R41

R43

Xi

R: 41-43

S: (2-)24-26-37/39

 

 

602-106-00-8

2-bromo-4,6-difluoroaniline

 

429-430-0

444-14-4

Xn; R22

N; R51-53

Xn; N

R: 22-51/53

S: (2-)25-61

 

 

602-107-00-3

3,3,4,4-tetrafluoro-4-iodo-1-butene

 

439-500-2

33831-83-3

Xn; R22

Xi; R38

N; R51-53

Xn; N

R: 22-38-51/53

S: (2-)37-61

 

 

602-108-00-9

(2,3,5,6-tetrafluorophenyl)methanol

 

443-840-7

4084-38-2

Xn; R22

Xi; R36

R43

Xn

R: 22-36-43

S: (2-)26-36/37

 

 

603-211-00-1

2,3-epoxypropyltrimethylammonium chloride … %;

glycidyl trimethylammonium chloride … %

B E

221-221-0

3033-77-0

Carc. Cat. 2; R45

Muta. Cat. 3; R68

Repr. Cat. 3; R62

Xn; R21/22-48/22

Xi; R41

R43

R52-53

T

R: 45-21/22-41-43-48/22-62-68-52/53

S: 53-45-61

 

 

603-212-00-7

1,3,4,6,7,8-hexahydro-4,6,6,7,8,8-hexamethylindeno[5,6-c]pyran;

galaxolide;

(HHCB)

 

214-946-9

1222-05-5

N; R50-53

N

R: 50/53

S: 60-61

 

 

603-213-00-2

2-methoxy-2-methylbutane;

tert-amyl methyl ether

 

213-611-4

994-05-8

F; R11

Xn; R22

R67

F; Xn

R: 11-22-67

S: (2-)9-16-23-33

 

 

603-214-00-8

1,1-diisopropoxycyclohexane

 

413-740-8

1132-95-2

C; R34

C

R: 34

S: (1/2-)23-26-36/37/39-45

 

 

603-215-00-3

1-hydroxy-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate)

 

418-330-2

162241-33-0

E; R2

Xn; R22-48/22

Xi; R41

R43

N; R50-53

E; Xn; N

R: 2-22-41-43-48/22-50/53

S: (2-)22-26-36/37/39-60-61

 

 

603-216-00-9

cis-1-amino-2,3-dihydro-1H-inden-2-ol

 

422-660-2

7480-35-5

Xi; R41

R43

R52-53

Xi

R: 41-43-52/53

S: (2-)24-26-37/39-61

 

 

603-217-00-4

2,4,6-tri-tert-butylphenyl 2-butyl-2-ethyl-1,3-propanediolphosphite

 

423-560-1

161717-32-4

R43

R53

Xi

R: 43-53

S: (2-)24-37/39-61

 

 

603-220-00-0

1-{benzyl[2-(2-methoxyphenoxy)ethyl]amino}-3-(9H-carbazol-4-yloxy)propan-2-ol

 

432-890-5

72955-94-3

R53

R: 53

S: 61

 

 

603-221-00-6

1-(2-amino-5-chlorophenyl)-2,2,2-trifluoro-1,1-ethanediol, hydrochloride;

[containing < 0,1 % 4-chloroaniline (EC No 203-401-0)]

 

433-580-2

214353-17-0

Xn; R22

C; R34

N; R51-53

C; N

R: 22-34-51/53

S: (1/2-)26-36/37/39-45-61

 

 

603-221-01-3

1-(2-amino-5-chlorophenyl)-2,2,2-trifluoro-1,1-ethanediol, hydrochloride;

[containing ≥ 0,1 % 4-chloroaniline (EC No 203-401-0)]

E

433-580-2

214353-17-0

Carc. Cat. 2; R45

Xn; R22

C; R34

N; R51-53

T; N

R: 45-22-34-51/53

S: 53-45-61

 

 

603-222-00-1

(2R,3S,4R,5R,7R,9R,10R,11S,12S,13R)-10-[(4-dimethylamino-3-hydroxy-6-methyltetrahydropyran-2-yl)oxy]-2-ethyl-3,4,12-trihydroxy-9-methoxy-3,5,7,9,11,13-hexamethyl-6,14-dioxo-1-oxacyclotetradecane

 

433-820-6

118058-74-5

Xi; R36

Xi

R: 36

S: (2-)26

 

 

603-223-00-7

2-cyclopentylidene cyclopentanol;

1,1′-bi(cyclopentyliden)-2-ol

 

434-270-1

6261-30-9

Xi; R38-41

R52-53

Xi

R: 38-41-52/53

S: (2-)26-37/39-61

 

 

603-224-00-2

3-ethoxy-1,1,1,2,3,4,4,5,5,6,6,6-dodecafluoro-2-(trifluoromethyl)-hexane

 

435-790-1

297730-93-9

R53

R: 53

S: 61

 

 

603-225-00-8

erythromycin A9-oxime (E);

(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-((2,6-didesoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopiranosyl)oxy)-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-((3,4,6-tridesoxy-3-dimethylamino-β-D-xylohexapiranosyl)oxy)oxacyclotetradecan-2-ona-10-oxime (E)

 

437-070-0

13127-18-9

N; R51-53

N

R: 51/53

S: 61

 

 

603-226-00-3

4,4′(4-(4-methoxyphenyl)-1,3,5-triazin-2,4-diyl)bisbenzene-1,3-diol

 

444-500-0

1440-00-2

R52-53

R: 52/53

S: 61

 

 

603-227-00-9

α-hydro-ω-[[[(1,1-dimethylethyl)dioxy]carbonyl]oxy]-poly[oxy(methyl-1,2-ethanediyl)] ether with 2,2-bis(hydroxymethyl)-1,3-propanediol (4:1);

reaction product of: α-hydro-ω-((chlorocarbonyl)oxy)-poly(oxy(methyl-1,2-ethanediyl)) ether with 2,2-bis(hydroxymethyl)-1,3-propanediol with potassium 1,1-dimethylethylperoxalate

 

445-060-2

203574-04-3

O; R7

N; R50-53

O; N

R: 7-50/53

S: (2-)3/7-14-36/37/39-60-61

 

 

603-228-00-4

(+/-)-(R*,R*)-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran;

6-fluoro-2-(2-oxiranyl)chromane

 

419-620-1

R43

N; R51-53

Xi; N

R: 43-51/53

S: (2-)36/37-61

 

 

603-229-00-X

sodium (Z)-3-chloro-3-(4-chlorophenyl)-1-hydroxy-2-propene-1-sulfonate

 

420-800-7

Xi; R38-41

R43

N; R50-53

Xi; N

R: 38-41-43-50/53

S: (2-)24-26-37/39-60-61

 

 

603-230-00-5

2,6,6,7,8,8-hexamethyldecahydro-2H-indeno[4,5-b]furan

 

440-030-5

Xi; R38-41

R53

Xi

R: 38-41-53

S: (2-)26-37/39-61

 

 

603-231-00-0

(S)-1,1-diphenyl-1,2-propanediol

 

443-220-6

R52-53

R: 52/53

S: 22-61

 

 

603-232-00-6

3,3,8,8,10,10-hexamethyl-9-[1-(4-oxiranylmethoxy-phenyl)-ethoxy]-1,5-dioxa-9-aza-spiro[5.5]undecane

 

444-420-6

R53

R: 53

S: 61

 

 

603-233-00-1

mixture of: 4-(1,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)-3-methylbutan-2-ol;

4-(3,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)-3-methylbutan-2-ol;

1-(1,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)pentan-3-ol;

1-(3,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)pentan-3-ol;

(E)-4-(3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoinden-5-yl)-3-methylbut-3-en-2-ol;

(E)-4-(3a,4,5,6,7,7a-hexahydro-3H-4,7-methanoinden-5-yl)-3-methylbut-3-en-2-ol

 

444-430-0

N; R51-53

N

R: 51/53

S: 61

 

 

603-234-00-7

(1R,4R)-4-methoxy-2,2,7,7-tetramethyltricyclo(6.2.1.0(1,6))undec-5-ene

 

444-480-3

Xi; R38

N; R51-53

Xi; N

R: 38-51/53

S: (2-)37-61

 

 

604-074-00-0

tetrabromobisphenol-A;

2,2′,6,6′-tetrabromo-4,4′-isopropylidenediphenol

 

201-236-9

79-94-7

N; R50-53

N

R: 50/53

S: 60-61

 

 

604-075-00-6

4-(1,1,3,3-tetramethylbutyl)phenol;

4-tert-octylphenol

 

205-426-2

140-66-9

Xi; R38-41

N; R50-53

Xi; N

R: 38-41-50/53

S: (2-)26-37/39-60-61

C ≥ 20 %: Xi, N; R38-41-50/53

10 % ≤ C < 20 %: Xi, N; R41-50/53

5 % ≤ C < 10 %: Xi, N; R36-50/53

2,5 % ≤ C < 5 %: N; R50/53

0,25 % ≤ C < 2,5 %: N; R51/53

0,025 % ≤ C < 0,25 %: R52/53

 

604-076-00-1

phenolphthalein

 

201-004-7

77-09-8

Carc. Cat. 2; R45

Muta. Cat. 3; R68

Repr. Cat. 3; R62

T

R: 45-62-68

S: 53-45

C ≥ 5 %: T; R45-62-68

1 % ≤ C < 5 %: T; R45-68

 

604-077-00-7

2-benzotriazol-2-yl-4-methyl-6-(2-methylallyl)phenol

 

419-750-9

98809-58-6

R53

R: 53

S: 61

 

 

604-079-00-8

4,4′-(1,3-phenylene-bis(1-methylethylidene))bis-phenol

 

428-970-4

13595-25-0

Repr.Cat.3; R62

R43

N; R51-53

Xn; N

R: 43-62-51/53

S: (2-)22-36/37-61

 

 

604-080-00-3

4-fluoro-3-trifluoromethylphenol

 

432-560-0

61721-07-1

Xn; R20

C; R35

R43

N; R51-53

C; N

R: 20-35-43-51/53

S: (1/2-)26-28-36/37/39-45-61

 

 

604-081-00-9

1,1-bis(4-hydroxyphenyl)-1-phenylethane

 

433-130-5

1571-75-1

N; R50-53

N

R: 50/53

S: 25-60-61

 

 

604-082-00-4

2-chloro-6-fluoro-phenol

E

433-890-8

2040-90-6

Muta.Cat.2; R46

Repr.Cat.3; R62

Xn; R22

C; R34

R43

N; R51-53

T; N

R: 46-22-34-43-62-51/53

S: 53-45-61

 

 

604-083-00-X

4,4′-sulfonylbisphenol, polymer with ammonium chloride(NH4Cl), pentachlorophosphorane and phenol

 

439-270-3

260408-02-4

R53

R: 53

S: 61

 

 

604-084-00-5

1-ethoxy-2,3-difluorobenzene

 

441-000-4

121219-07-6

Xn; R22

R52-53

Xn

R: 22-52/53

S: (2-)23-61

 

 

604-087-00-1

mixture of: 1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)monoester with 4,4′-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol;

1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)diester with 4,4′-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol;

1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)triester with 4,4′-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol

 

433-640-8

F; R17

R44

R53

F

R: 17-44-53

S: (2-)15-22-61

 

 

604-089-00-2

2-methyl-5-tert-butylthiophenol

 

444-970-7

R10

Repr.Cat.3; R63

Xn; R48/20/22-65

Xi; R36/38

R43

R67

N; R50-53

Xn; N

R: 10-36/38-43-48/20/22-63-65-67-50/53

S: (2-)26-36/37-62-60-61

 

 

605-037-00-1

trans-3-[2-(7-chloro-2-quinolinyl)vinyl]benzaldehyde;

3-[(E)-2-(7-chloro-2-quinolinyl)vinyl]benzaldehyde

 

421-800-1

120578-03-2

R53

R: 53

S: 22-61

 

 

605-038-00-7

3-methyl-5-phenylpentan-1-al

 

433-900-0

55066-49-4

Xn; R22

Xi; R38

R43

N; R51-53

Xn; N

R: 22-38-43-51/53

S: (2-)36/37-61

 

 

605-039-00-2

3,4-dihydroxy-5-nitrobenzaldehyde

 

441-810-8

116313-85-0

Xn; R22

Xi; R41

R43

Xn

R: 22-41-43

S: (2-)22-24-26-37/39

 

 

606-124-00-7

1-cyclopropyl-3-(2-methylthio-4-trifluoromethylphenyl)-1,3-propanedione

 

421-080-7

161462-35-7

Xn; R48/22

N; R50-53

Xn; N

R: 48/22-50/53

S: (2-)36-60-61

 

 

606-125-00-2

1-benzylimidazolidine-2,4-dione

 

421-340-1

6777-05-5

Xn; R22

Xn

R: 22

S: (2-)22

 

 

606-126-00-8

1,4-bis(2,3-dihydroxypropylamino)anthraquinone

 

421-470-7

99788-75-7

N; R51-53

N

R: 51/53

S: 61

 

 

606-128-00-9

2,2′-(1,3-phenylene)bis[5-chloro-1H-isoindole]-1,3(2H)-dione

 

422-650-8

148935-94-8

R53

R: 53

S: 61

 

 

606-129-00-4

5-amino-[2S-di(methylphenyl)amino]-1,6-diphenyl-4Z-hexen-3-one;

(2S,4Z)-5-amino-2-(dibenzylamino)-1,6-diphenylhex-4-en-3-one

 

423-090-7

156732-13-7

R53

R: 53

S: 61

 

 

606-130-00-X

4-(1,4-dioxa-spiro[4.5]dec-8-yl)-cyclohexanone

 

423-860-2

56309-94-5

R43

R52-53

Xi

R: 43-52/53

S: (2-)24-37-61

 

 

606-131-00-5

cyclic 3-(1,2-ethanediylacetale)-estra-5(10),9(11)-diene-3,17-dione

E

427-230-8

5571-36-8

Repr. Cat. 2; R60

Xn; R48/22

N; R51-53

T; N

R: 60-48/22-51/53

S: 53-45-61

 

 

606-132-00-0

(6β)-6,19-epoxyandrost-4-ene-3,17-dione

 

433-490-3

6563-83-3

R43

R52-53

Xi

R: 43-52/53

S: (2-)24-37-61

 

 

606-134-00-1

androsta-1,4,9(11)-triene-3,17-dione

 

433-560-3

15375-21-0

Repr. Cat.3; R62

Xn

R: 62

S: (2-)22-36/37

 

 

606-135-00-7

cyclohexadecanone

 

438-930-8

2550-52-9

R53

R: 53

S: 61

 

 

606-136-00-2

(3S,6R,9S,12R,15S,18R,21S,24R)-6,18-dibenzyl-3,9,15,21-tetraisobutyl-4,10,12,16,22,24-hexamethyl-1,7,13,19-tetraoxa-4,10,16,22-tetraazacyclo-tetracosane-2,5,8,11,14,17,20,23-octaone

 

444-350-6

133413-70-4

Xi; R36

R53

Xi

R: 36-53

S: (2-)26-61

 

 

606-137-00-8

trans-7,7′-dimethyl-(4H,4H′)-(2,2′)bi[benzo[1,4]thiazinylidene]-3,3′-dione

 

444-750-0

211387-26-7

R53

R: 53

S: 22-61

 

 

606-138-00-3

(2-butyl-5-nitrobenzofuran-3-yl)[4-(3-dibutylaminopropoxy)phenyl]methanone

 

444-800-1

141645-23-0

R10

Xn; R22-48/22

Xi; R38-41

R43

N; R50-53

Xn; N

R: 10-22-38-41-43-48/22-50/53

S: (2-)23-26-36/37/39-60-61

C ≥ 25 %: Xn, N; R22-38-41-43-48/22-50/53

20 % ≤ C < 25 %: Xn, N; R38-41-43-48/22-50/53

10 % ≤ C < 20 %: Xn, N; R41-43-48/22-50/53

5 % ≤ C < 10 %: Xi, N; R36-43-50/53

2,5 % ≤ C < 5 %: Xi, N; R43-50/53

1 % ≤ C < 2,5 %: Xi, N; R43-51/53

0,25 % ≤ C < 1 %: N; R51/53

0,025 % ≤ C < 0,25 %: R52/53

 

606-139-00-9

(S)-4-(3,4-dichlorophenyl)-3,4-dihydro-2H-naphthalen-1-one

 

444-830-5

124379-29-9

R53

R: 53

S: 61

 

 

606-140-00-4

2-hydroxy-1-(4-(4-(2-hydroxy-2-methylpropionyl)benzyl)phenyl)-2-methylpropan-1-one

 

444-860-9

474510-57-1

Xn; R48/22

N; R50-53

Xn; N

R: 48/22-50/53

S: (2-)22-36-60-61

 

 

606-141-00-X

sodium 3-(methoxycarbonyl)-4-oxo-3,4,5,6-tetrahydro-2-pyridinolate

 

418-410-7

Xi; R36

Xi

R: 36

S: (2-)26

 

 

606-142-00-5

mixture of: (1RS,2SR,7SR,8SR,E) 9 and 10-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one;

(1RS,2SR,7SR,8SR,Z)-10-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one;

(1RS,2SR,7SR,8SR,Z)-9-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one

 

434-290-9

Xn; R22

N; R51-53

Xn; N

R: 22-51/53

S: (2-)61

 

 

607-580-00-X

ethyl 7-chloro-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylate

 

422-360-1

100491-29-0

R43

N; R51-53

Xi; N

R: 43-51/53

S: (2-)22-24-37-61

 

 

607-618-00-5

menadione sodium bisulfite;

2-naphthalenesulfonic acid,1,2,3,4-tetrahydro-2-methyl-1,4-dioxo-, sodium salt

 

204-987-0

130-37-0

Xi; R36/38

N; R50-53

Xi; N

R: 36/38-50/53

S: (2-)24/25-60-61

 

 

607-619-00-0

menadione nicotinamide bisulfite;

1,2,3,4-tetrahydro-2-methyl-1,4-dioxonaphthalene-2-sulfonic acid, compound with nicotin-3-amide (1:1)

 

277-543-7

73581-79-0

Xi; R36/38

N; R50-53

Xi; N

R: 36/38-50/53

S: (2-)24/25-60-61

 

 

607-620-00-6

trisodium nitrilotriacetate

 

225-768-6

5064-31-3

Carc. Cat. 3; R40

Xn; R22

Xi; R36

Xn

R: 22-36-40

S: (2-)26-36/37-46

C ≥ 25 %: Xn; R22-36-40

20 ≤ % C < 25 %: Xn; R36-40

5 ≤ % C < 20 %: Xn; R40

 

607-621-00-1

milbemectin (ISO);

[mixture of milbemycin A3 (CAS No 51596-10-2) and milbemycin A4 (CAS No 51596-11-3) (30:70)]

 

Xn; R20/22

N; R50-53

Xn; N

R: 20/22-50/53

S: (2-)46-60-61

C ≥ 25 %: Xn, N; R20/22-50/53

0,25 % ≤ C < 25 %: N; R50/53

0,025 % ≤ C < 0,25 %: N; R51/53

0,0025 % ≤ C < 0,025 %: R52/53

 

607-622-00-7

2-ethylhexyl-2-ethylhexanoate

 

231-057-1

7425-14-1

Repr. Cat. 3; R63

Xn

R: 63

S: (2-)36/37

 

 

607-623-00-2

diisobutyl phthalate

 

201-553-2

84-69-5

Repr. Cat. 2; R61

Repr. Cat. 3; R62

T

R: 61-62

S: 53-45

C ≥ 25 %: T; R61-62

5 % ≤ C < 25 %: Xn; R62

 

607-624-00-8

perfluorooctane sulfonic acid;

heptadecafluorooctane-1-sulfonic acid; [1]

potassium perfluorooctanesulfonate;

potassium heptadecafluorooctane-1-sulfonate; [2]

diethanolamine perfluorooctane sulfonate; [3]

ammonium perfluorooctane sulfonate;

ammonium heptadecafluorooctanesulfonate; [4]

lithium perfluorooctane sulfonate;

lithium heptadecafluorooctanesulfonate [5]

E

217-179-8 [1]

220-527-1 [2]

274-460-8 [3]

249-415-0 [4]

249-644-6 [5]

1763-23-1 [1]

2795-39-3 [2]

70225-14-8 [3]

29081-56-9 [4]

29457-72-5 [5]

Carc. Cat. 3; R40

Repr. Cat. 2; R61

T; R48/25

Xn; R20/22

R64

N; R51-53

T; N

R: 61-20/22-40-48/25-64-51/53

S: 53-45-61

 

 

607-625-00-3

clodinafop-propargyl (ISO)

 

105512-06-9

Xn; R22-48/22

R43

N; R50-53.

Xn; N

R: 22-43-48/22-50/53

S: (2-)24-36/37-46-60-61

C ≥ 25 %: Xn, N; R22-43-48/22-50/53

10 % ≤ C < 25 %: Xn, N; R43-48/22-51/53

2,5 % ≤ C < 10 %: Xi, N; R43-51/53

0,25 % ≤ C < 2,5 %: Xi; R43-52/53

0,001 % ≤ C < 0,25 %: Xi; R43

 

607-626-00-9

ethyl 1-(2,4-dichlorophenyl)-5-(trichloromethyl)-1H-1,2,4-triazole-3-carboxylate

 

401-290-5

103112-35-2

Carc.Cat.2; R45

N; R50-53

T; N

R: 45-50/53

S: 53-45-60-61

 

 

607-627-00-4

[(4S,5S)-4-benzyl-2-oxo-5-oxazolidinyl]methyl 4-nitrobenzenesulfonate

 

416-360-0

162221-28-5

R43

Xi

R: 43

S: (2-)22-24-37

 

 

607-628-00-X

4-oxo-4-(p-tolyl)butyric acid adduct with 4-ethylmorpholine

 

419-240-6

171054-89-0

Xi; R41

Xi

R: 41

S: (2-)26-39

 

 

607-629-00-5

[[2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphinyl] acetic acid

 

419-270-1

123599-82-6

Xi; R36

Xi

R: 36

S: (2-)26

 

 

607-630-00-0

acrylic acid, 3-(trimethoxysilyl)propyl ester

 

419-560-6

4369-14-6

Xn; R20

C; R34

R43

R52-53

C

R: 20-34-43-52/53

S: (1/2-)26-36/37/39-45-61

 

 

607-631-00-6

mixture of: 2-(2-((oxo(phenyl)acetyl)oxy)ethoxy)ethyl oxo(phenyl)acetate;

(2-(2-hydroxyethoxy)ethyl) oxo(phenyl)acetate

 

442-300-8

R43

Xi

R: 43

S: (2-)24-37

 

 

607-632-00-1

N-[3-(2,4-di-(1,1-dimethyl-propyl)phenoxy)-propyl]-1-hydroxy-5-(2-methylpropyl-oxycarbonylamino)-naphthamide

 

420-210-1

111244-14-5

R53

R: 53

S: 61

 

 

607-633-00-7

trisodium 5-{[4-chloro-6-(1-naphthylamino)-1,3,5-triazin-2-yl]amino}-4-hydroxy-3-[(E)-(4-methoxy-2-sulfonatophenyl)diazenyl]-2,7-naphthalenedisulfonate

 

440-480-2

341026-59-3

Xi; R41

R43

Xi

R: 41-43

S: (2-)22-24-26-37/39

 

 

607-634-00-2

(S)-(-)-2-acetoxypropionylchloride;

(1S)-2-chloro-1-methyl-2-oxoethyl acetate

 

420-610-4

36394-75-9

Xn; R22

C; R34

R43

C

R: 22-34-43

S: (1/2-)23-26-36/37/39-45

 

 

607-635-00-8

trisodium N-(3-propionato)-L-aspartate

 

422-090-4

172737-80-3

Xi; R41

Xi

R: 41

S: (2-)26-39

 

 

607-636-00-3

1-bromo-2-methylpropyl propionate

 

422-900-6

158894-67-8

R10

Carc.Cat.3; R40

C; R34

R43

C

R: 10-34-40-43

S: (1/2-)7/9-8-23-26-36/37/39-45

 

 

607-637-00-9

disodium 8-amino-5-{4-[2-(sulfonatoethoxy)sulfonyl]phenylazo}naphthalene-2-sulfonate

 

423-730-5

250688-43-8

Xi; R41

Xi

R: 41

S: (2-)26-39

 

 

607-638-00-4

2-hydroxybenzoic acid 2-butyloctyl ester

 

431-090-3

190085-41-7

R53

R: 53

S: 61

 

 

607-639-00-X

2-(2-oxo-5-(1,1,3,3-tetramethylbutyl)-2,3-dihydro-1-benzofuran-3-yl)-4-(1,1,3,3-tetramethylbutyl)phenyl acetate

 

431-770-1

216698-07-6

R53

R: 53

S: 61

 

 

607-641-00-0

2-(formylamino)-3-thiophenecarboxylic acid;

2-formamido-3-thiophenecarboxylic acid

 

431-930-9

43028-69-9

Xn; R22

R43

Xn

R: 22-43

S: (2-)22-24-37

 

 

607-642-00-6

3,6,9-trithiaundecamethylene-1,11-dimethacrylate

 

432-210-7

141631-22-3

N; R50-53

N

R: 50/53

S: 60-61

 

 

607-643-00-1

dimethyl (2S)-2-hydroxysuccinate

 

432-310-0

617-55-0

R10

Xi; R41

R43

Xi

R: 10-41-43

S: (2-)24-26-37/39-43

 

 

607-644-00-7

methyl 2,2-dimethyl-6-methylenecyclohexanecarboxylate

 

432-350-9

81752-87-6

Xi; R38

Xi

R: 38

S: (2-)37

 

 

607-645-00-2

tetrasodium 2-(4-fluoro-6-(methyl-(2-(sulfatoethylsulfonyl)ethyl)amino)-1,3,5-triazin-2-ylamino)-5-hydroxy-6-(4-methyl-2-sulfonatophenylazo)naphthalene-1,7-disulfonate

 

432-550-6

243858-01-7

Xi; R41

Xi

R: 41

S: (2-)22-26-39

 

 

607-646-00-8

D-erythro-hexanoic acid 2,4-dideoxy-3,5-O-(1-methylethylidene)-1,1-dimethylethylester;

tert-butyl 2-[(4R,6S)-6-(hydroxymethyl)-2,2-dimethyl-1,3-dioxan-4-yl]acetate

 

432-960-5

124655-09-0

Xn; R22

Xn

R: 22

S: (2-)25

 

 

607-647-00-3

5-acetoxy-2-(R,S)butyryloxymethyl-1,3-oxathiolane

 

433-530-1

143446-73-5

Xn; R22

R43

N; R50

Xn; N

R: 22-43-50

S: (2-)24-37-57-61

 

 

607-649-00-4

[3-(chlorocarbonyl)-2-methylphenyl]acetate

 

433-690-0

167678-46-8

C; R35

R43

C

R: 35-43

S: (1/2-)7/8-26-36/37/39-45

 

 

607-650-00-X

2-methyl-1,5-pentanediamine-1,3-benzenedicarboxylate

 

433-910-5

145153-52-2

R43

Xi

R: 43

S: (2-)24-37

 

 

607-651-00-5

sodium 2-(nonanoyloxy)benzenesulfonate

 

434-360-9

91125-43-8

Xi; R41

R43

Xi

R: 41-43

S: (2-)24-26-37/39

 

 

607-652-00-0

ethyl N 2-dodecanoyl-L-argininate hydrochloride

 

434-630-6

60372-77-2

Xi; R41

N; R50

Xi; N

R: 41-50

S: (2-)26-39-61

 

 

607-653-00-6

tetrakis(bis(2-hydroxyethyl)methylammonium) 3-(4-(7-acetylamino-1-hydroxy-3-sulfonatonaphthalen-2-ylazo)-5-methoxy-2-sulfonatophenylazo)-7-(4-amino-3-sulfonatophenylamino)-4-hydroxynaphthalene-2-sulfonate

 

434-840-8

225786-91-4

N; R51-53

N

R: 51/53

S: 61

 

 

607-654-00-1

(S)-3-hydroxy-γ-butyrolactone

 

434-990-4

7331-52-4

R43

Xi

R: 43

S: (2-)23-24-37

 

 

607-655-00-7

ethyl 6,8-dichlorooctanoate

 

435-080-1

1070-64-0

R43

N; R51-53

Xi; N

R: 43-51/53

S: (2-)24-37-61

 

 

607-656-00-2

sodium salt of 4-amino-3,6-bis[[5-[[4-chloro-6-[(2-methyl-4-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]azo]-5-hydroxy-2,7-naphthalenedisulfonic acid

 

435-350-7

141250-43-3

Xi; R41

R52-53

Xi

R: 41-52/53

S: (2-)22-26-39-61

 

 

607-657-00-8

pentasodium 7-(4-(4-(3-(2-sulfatoethanesulfonyl)phenylamino)-6-(4-(2-sulfatoethanesulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate

 

436-920-8

172399-10-9

Xi; R41

Xi

R: 41

S: (2-)22-26-39

 

 

607-658-00-3

3,10-diamino-6,13-dichloro-2-((6-(((4-(1,1-dimethylethyl)phenyl)sulfonyl)amino)-2-naphthalenyl)sulfonyl)-4,11-triphenodioxazinedisulfonic acid, lithium potassium sodium salt

 

440-770-9

371921-63-0

Xi; R41

R52-53

Xi

R: 41-52/53

S: (2-)26-39-61

 

 

607-659-00-9

pentasodium N-[5-[[4-[[3-[(aminocarbonyl)amino]-4-[(3,6,8-trisulfonatonaphthalen-2-yl)azo]phenyl]amino]-6-chloro-1,3,5-triazin-2-yl]amino]-2-sulfonato-4-[[4-[[-2-(oxysulfonato)ethyl] sulfonyl]phenyl]azo]phenyl]-3-aminopropanoic acid

 

442-030-0

321912-47-4

Xi; R41

Xi

R: 41

S: (2-)22-26-39

 

 

607-660-00-4

2-{4-[4-[4-fluoro-6-(2-(2-vinylsulfonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino]phenylazo]phenylazo}naphthalene-4,6,8-trisulfonate, trisodium salt

 

442-230-8

321679-52-1

Xi; R41

Xi

R: 41

S: (2-)22-26-39

 

 

607-661-00-X

1,1-dimethylethyl 4′-(bromomethyl)biphenyl-2-carboxylate

 

442-850-9

114772-40-6

R43

R53

Xi

R: 43-53

S: (2-)22-24-37-61

 

 

607-662-00-5

methyl 2-(acetylamino)-3-chloropropionate

 

442-860-3

87333-22-0

R43

N; R50-53

Xi; N

R: 43-50/53

S: (2-)24-37-60-61

 

 

607-663-00-0

bis(2-ethylhexyl) naphthalene-2,6-dicarboxylate

 

442-980-6

127474-91-3

R53

R: 53

S: 61

 

 

607-664-00-6

methyl 2-chlorosulfonyl-4-(methanesulfonylaminomethyl) benzoate

 

443-120-2

393509-79-0

Xi; R41

N; R51-53

Xi; N

R: 41-51/53

S: (2-)26-39-61

 

 

607-665-00-1

trans-methyl-2-ethyl-but-2-enoate

 

443-150-6

101226-85-1

R10

R: 10

S: 23

 

 

607-666-00-7

(2S)-5-(benzyloxy)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-5-oxopentanoic acid

 

443-560-5

88784-33-2

Xi; R36

Xi

R: 36

S: (2-)26

 

 

607-667-00-2

chloro-1-ethylcyclohexyl carbonate

 

444-950-8

99464-83-2

Muta.Cat.3; R68

R43

Xn

R: 43-68

S: (2-)23-36/37

 

 

607-668-00-8

trans-2-isopropyl-5-carboxy-1,3-dioxane

 

445-770-2

42031-28-7

Xi; R41

R52-53

Xi

R: 41-52/53

S: (2-)22-26-39-61

 

 

607-669-00-3

methyl (9-acetoxy-3,8,10-triethyl-7,8,10-trimethyl-1,5-dioxa-9-aza-spiro[5.5]undec-3-yl)octadecanoate

 

445-990-9

376588-17-9

R43

R53

Xi

R: 43-53

S: (2-)24-37-61

 

 

607-670-00-9

dibutyl-3-(4-(5-ammonio-2-butyl)benzofuran-3-yl)carbonyl)phenoxy)propyl ammonium oxalate;

(5-amino-2-butylbenzofuran-3-yl) [4-(3-dibutylaminopropoxy)phenyl]methanone, dioxalate

 

448-700-9

500791-70-8

Xn; R48/22

Xi; R41

R43

N; R50-53

Xn; N

R: 41-43-48/22-50/53

S: (2-)22-26-36/37/39-60-61

C ≥ 10 %: Xn, N; R41-43-48/22-50/53

5 % ≤ C < 10 %: Xi, N; R36-43-50/53

2,5 % ≤ C < 5 %: Xi, N; R43-50/53

1 % ≤ C < 2,5 %: Xi, N; R43-51/53

0,25 % ≤ C < 1 %: N; R51/53

0,025 % ≤ C < 0,25 %: R52/53

 

607-671-00-4

diethyl 1,4-cyclohexanedicarboxylate

 

417-310-0

72903-27-6

N; R51-53

N

R: 51/53

S: 61

 

 

607-672-00-X

mixture of: 2-hydroxy-3-(methacryloyloxy)propyl (2-benzoyl)benzoate;

1-hydroxymethyl-2-(methacryloyloxy)ethyl (2-benzoyl)benzoate;

x-hydroxy-y-(methacryloyloxy)propyl(or -ethyl) (2-benzoyl)benzoate

 

419-000-0

R43

N; R51-53

Xi; N

R: 43-51/53

S: (2-)24-37-61

 

 

607-673-00-5

1-ethyl-5,6,7,8-tetrahydroquinolinium tosylate

 

419-570-0

Xn; R22

R52-53

Xn

R: 22-52/53

S: (2-)61

 

 

607-674-00-0

branched C10-alkyl benzoates

 

421-090-1

131298-44-7

Xn; R20

Xn

R: 20

S: (2-)23

 

 

607-675-00-6

mixture of: cis-9-octadecenedioic acid;

cis-9-cis-12-octadecadienedioic acid;

hexadecanedioic acid;

octadecanedioic acid

 

422-260-8

Xi; R41

N; R50-53

Xi; N

R: 41-50/53

S: (2-)26-39-60-61

 

 

607-676-00-1

mixture of: 2-methylnonanedioic acid;

2,4-dimethyl-4-methoxycarbonylundecanedioic acid;

2,4,6-trimethyl-4,6-dimethoxycarbonyltridecanedioic acid;

8,9-dimethyl-8,9-dimethoxycarbonylhexadecanedioic acid

 

423-670-1

Xi; R41

R43

Xi

R: 41-43

S: (2-)24-26-37/39

 

 

607-677-00-7

2,5-dioxopyrrolidin-1-yl N-{[methyl[[2-(1-methylethyl)-4-thiazolyl]methyl]amino]carbonyl}-L-valinate

 

424-660-8

Xn; R48/22

Xi; R41

R43

Xn

R: 41-43-48/22

S: (2-)22-26-36/37/39

 

 

607-678-00-2

mixture of: ethyl (2R,3R)-3-isopropylbicyclo[2.2.1]hept-5-ene-2-carboxylate;

ethyl (2S,3S)-3-isopropylbicyclo[2.2.1]hept-5-ene-2-carboxylate

 

427-090-8

R43

N; R51-53

Xi; N

R: 43-51/53

S: (2-)23-25-36/37-61

 

 

607-679-00-8

mixture of: 3-{5-[3-(4-{1,6-dihydro-2-hydroxy-4-methyl-1-[3-(methylammonio)propyl]-6-oxo-3-pyridylazo}benzamido)phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(methyl)ammonium di(acetate);

3-{5-[4-(3-{1,6-dihydro-2-hydroxy-4-methyl-1-[3-(methylammonio)propyl]-6-oxo-3-pyridylazo}benzamido]phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(dimethyl)ammonium di(acetate);

3-{5-[3-(4-{1-[3-(dimethylammonio)propyl]-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo}benzamido)phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(dimethyl)ammonium di(acetate)

 

431-440-5

Xi; R41

N; R51-53

Xi; N

R: 41-51/53

S: (2-)22-26-39-61

 

 

607-680-00-3

tert-butyl(6-{2-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]vinyl}(4S,6S)-2,2-dimethyl[1,3]dioxan-4-yl)acetate

 

432-810-9

R53

R: 53

S: 61

 

 

607-681-00-9

mixture of: 9-nonyl-10-octyl-19-carbonyloxyhexadecylnonadecanoic acid;

9-nonyl-10-octyl-19-carbonyloxyoctadecylnonadecanoic acid;

dihexadecyl 9-nonyl-10-octylnonadecandioate;

1-octadecyl,19-hexadecyl 9-nonyl-10-octylnonadecandioate;

dioctadecyl 9-nonyl-10-octylnonadecandioate

 

432-910-2

R53

R: 53

S: 61

 

 

607-682-00-4

complex mixture of Chinese gum rosin post reacted with acrylic acid

 

434-230-1

144413-22-9

R53

R: 53

S: 61

 

 

607-683-00-X

mixture of: methyl 3-((1E)-2-methylprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate;

methyl 3-((1Z)-2-methylprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate (20:80)

 

435-450-0

R43

N; R51-53

Xi; N

R: 43-51/53

S: (2-)24-37-61

 

 

607-684-00-5

alkenes, C12-14, hydroformylation products, distn. residues, C-(hydrogen sulfobutanedioates), disodium salts

 

435-660-2

243662-67-1

Xi; R38

R43

Xi

R: 38-43

S: (2-)24-37

 

 

607-685-00-0

ammonium 2-cocoyloxyethanesulfonate

 

441-050-7

Xi; R38-41

Xi

R: 38-41

S: (2-)26-37/39

 

 

607-686-00-6

6,6′-bis(diazo-5,5′,6,6′-tetrahydro-5,5′-dioxo)[methylene-bis(5-(6-diazo-5,6-dihydro-5-oxo-1-naphthylsulphonyloxy)-6-methyl-2-phenylene]di(naphthalene-1-sulfonate)

 

441-550-5

E; R2

F; R11

Carc. Cat. 3; R40

E; Xn

R: 2-11-40

S: (2-)7-22-36/37

 

 

607-687-00-1

mixture of: 2-{3,6-bis-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %);

2-{3,6-bis-[(2,3-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %);

2-{3,6-bis-[(2,4-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %);

2-{3,6-bis-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %);

2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %);

2-{3-[(2,4-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %);

2-{3-[(2,5-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %);

2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2,4-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %);

2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %);

2-{3-[(2,4-dimethylphenyl)-methylamino]-6-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %)

 

442-800-6

Xi; R38

N; R51-53

Xi; N

R: 38-51/53

S: (2-)37-61

 

 

607-688-00-7

(R)-1-cyclohexa-1,4-dienyl-1-methoxycarbonyl-methylammoniumchloride

 

444-320-2

Xn; R22

Xn

R: 22

S: (2-)

 

 

607-689-00-2

mixture of: methyl 1,4-dimethylcyclohexanecarboxylate (‘para-isomer’ including cis- and trans- isomers);

methyl 1,3-dimethylcyclohexanecarboxylate (‘meta-isomer’ including cis- and trans-isomers)

 

444-920-4

R52-53

R: 52/53

S: 61

 

 

607-690-00-8

dimethyl[2S,2S′]-6,6,6′6′-tetramethoxy-2,2′-[N,N′-bis(trifluoracetyl)-S,S′-bi(L-homocysteinyl) diimino]dihexanoate

 

432-860-1

255387-46-3

R43

Xi

R: 43

S: (2-)24-37

 

 

607-691-00-3

magnesium salts, fatty acids, C16-18 and C18 unsaturated, branched and linear

 

448-690-6

R53

R: 53

S: 61

 

 

607-692-00-9

zinc salts, fatty acids, C16-18 and C18 unsaturated, branched and linear

 

446-470-4

R53

R: 53

S: 61

 

 

607-693-00-4

hexyl 2-(1-(diethylaminohydroxyphenyl)methanoyl)benzoate

 

443-860-6

302776-68-7

R53

R: 53

S: 61

 

 

607-694-00-X

ethyl 5,5-diphenyl-2-isoxazoline-3-carboxylate

 

443-870-0

163520-33-0

Xn; R22

R43

N; R50-53

Xn; N

R: 22-43-50/53

S: (2-)22-36/37-60-61

 

 

608-042-00-7

(S)-2,2-diphenyl-2-(3-pyrrolidinyl)acetonitrile hydrobromide

 

421-810-4

194602-27-2

Xn; R22

Xi; R41

R43

N; R51-53

Xn; N

R: 22-41-43-51/53

S: (2-)24-26-37/39-61

 

 

608-059-00-X

5-amino-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-1H-pyrazole-3-carbonitrile

 

421-240-6

120068-79-3

N; R51-53

N

R: 51/53

S: 22-61

 

 

608-060-00-5

5-methyl-2-[(2-nitrophenyl)amino]-3-thiophenecarbonitrile

 

421-300-1

138564-59-7

N; R50-53

N

R: 50/53

S: 22-60-61

 

 

608-062-00-6

2-fluoro-4-hydroxybenzonitrile

 

422-810-7

82380-18-5

Xn; R22

Xi; R41

N; R51-53

Xn; N

R: 22-41-51/53

S: (2-)22-26-39-61

 

 

608-063-00-1

(S)-α-hydroxy-3-phenoxy-benzeneacetonitrile

 

441-070-6

61826-76-4

T; R25

Xi; R41

R43

N; R50-53

T; N

R: 25-41-43-50/53

S: (1/2-)9-26-36/37/39-45-60-61

 

 

608-064-00-7

cyanomethyltrimethylammoniummethylsulfate

 

433-720-2

R52-53

R: 52/53

S: 61

 

 

609-069-00-7

musk ketone;

3,5-dinitro-2,6-dimethyl-4-tert-butylacetophenone;

4′-tert-butyl-2′,6′-dimethyl-3′,5′-dinitroacetophenone

 

201-328-9

81-14-1

Carc. Cat. 3; R40

N; R50-53

Xn; N

R: 40-50/53

S: (2-)36/37-46-60-61

 

 

611-154-00-9

trisodium 5-benzamido-4-hydroxy-3-(4-methyl-2-sulfonatophenylazo)naphthalene-2,7-disulfonate

 

403-670-6

92408-46-3

R52-53

R: 52/53

S: 61

 

 

611-155-00-4

4,4′-oxybis(benzenesulfonylazide)

 

431-850-4

7456-68-0

E; R3

F; R11

Xn; R48/22

N; R50-53

E; Xn; N

R: 3-11-48/22-50/53

S: (2-)14-22-33-35-36-60-61

 

 

611-156-00-X

triammonium 4-[4-[7-(4-carboxylatoanilino)-1-hydroxy-3-sulfonato-2-naphthylazo]-2,5-dimethoxyphenylazo]benzoate

 

432-270-4

221354-37-6

Repr. Cat. 3; R62

Xn; R48/22

N; R51-53

Xn; N

R: 48/22-62-51/53

S: (2-)36/37-61

 

 

611-157-00-5

benzenesulfonic acid, 3,3′-(methylenebis((dihydroxyphenylene)azo))bis-, potassium sodium salt;

potassium sodium 3-[(E)-(6-{3,4-dihydroxy-2-[(Z)-(3-sulfonatophenyl)diazenyl]benzyl}-2,3-dihydroxyphenyl)diazenyl]benzenesulfonate

 

432-590-4

243869-48-9

Xi; R36

R52-53

Xi

R: 36-52/53

S: (2-)26-61

 

 

611-158-00-0

reaction mixture of: 2,3,4,2′,3′,4′-hexahydroxy-5,5′-diacethyl-diphenylmethane and 6-diazo-5,6-dihydro-5-oxo-1-naphthalenesulfonylchloride and 3-diazo-3,4-dihydro-6-methoxy-4-oxo-1-naphthalenesulfonylchloride

 

421-520-8

F; R11

R53

F

R: 11-53

S: (2-)3-12-16-33-61

 

 

611-159-00-6

disodium 4-amino-6-((4-((4-(2,4-diaminophenyl)azo)phenylsulfamoyl)phenyl)azo)-5-hydroxy-3-((4-nitrophenyl)azo)naphthalene-2,7-disulfonate

 

421-880-6

Xi; R41

R52-53

Xi

R: 41-52/53

S: (2-)26-39-61

 

 

611-160-00-1

mixture of: 1,1,1-tris(phenyl-4′-(3″-diazo-3″,4″-dihydro-4″-oxo-naphthalene-1″-sulfonato)ethane;

1,1,1-tris(phenyl-4′-(6″-diazo-5″,6″-dihydro-5″-oxo-naphthalene-1″-sulfonato)ethane;

reaction product of 1,1,1-tris(p-hydroxyphenyl)ethane with 6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonylchloride and 3-diazo-3,4-dihydro-4-oxo-1-naphthylsulfonylchloride (2:1);

reaction product of 1,1,1-tris(p-hydroxyphenyl)ethane with 6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonylchloride and 3-diazo-3,4-dihydro-4-oxo-1-naphthylsulfonylchloride (1:2)

 

422-760-6

F; R11

R53

F

R: 11-53

S: (2-)3-12-33-61

 

 

611-161-00-7

trisodium [1,2′-(2-(8-amino-3,5-disulfonatonaphthalene)azo)-(4′-nitrobenzene)diolato-O,O,N][(Z)-2,2-((phenylcarbamoylprop-1′-enyl)azo)-5-sulfamoylbenzene)diolato-O,O,N]chromate(III)

 

423-100-1

Xi; R41

Xi

R: 41

S: (2-)26-39

 

 

611-162-00-2

2,4-bis(((2-(dimethylammonio)ethyloxy)carbonyl)phen-2-ylazo)benzene-1,3-diolbis(methanesulfonate)

 

429-600-4

Xn; R22

Xi; R41

N; R51-53

Xn; N

R: 22-41-51/53

S: (2-)22-26-39-61

 

 

611-163-00-8

2,4-bis(((2-(dimethylammonio)ethyloxy)carbonyl)phen-2-ylazo)benzene-1,3-diol sulfate

 

429-610-9

Xn; R22

Xi; R41

N; R51-53

Xn; N

R: 22-41-51/53

S: (2-)22-26-39-61

 

 

611-164-00-3

mixture of: 2,2′-dimethyl-2,2′-azobutanenitrile;

2-methylpentanenitrile-2-azo-2′-(2′-methylpropanenitrile);

2,2′-dimethyl-2,2′-azoheptanenitrile;

2-methylheptanenitrile-2-azo-2′-(2′-methylpropanenitrile);

2-methylheptanenitrile-2-azo-2′-(2′-methylbutanenitrile)

 

429-710-2

R10

R32

R44

Xn; R22

N; R51-53

Xn; N

R: 10-22-32-44-51/53

S: (2-)12-15-16-47-51-61

 

 

611-165-00-9

mixture of: tetrasodium 4-amino-6-(5-(2,6-difluoropyrimidin-4-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(sulfatoethylsulfonyl)phenylazo)naphthalene-2,7-disulfonate;

tetrasodium 4-amino-6-(5-(4,6-difluoropyrimidin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(2-sulfatoethylsulfonyl)phenylazo)naphthalene-2,7-disulfonate

 

431-830-5

R52-53

R: 52/53

S: 61

 

 

611-166-00-4

mixture of: pentasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}naphthalene-2,7-disulfonate;

tetrasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;

tetrasodium 4-amino-5-hydroxy-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-3-[(E)-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate

 

432-100-9

Xi; R41

R52-53

Xi

R: 41-52/53

S: (2-)26-39-61

 

 

611-167-00-X

sodium bis[tris(2-hydroxyethyl)ammonium][6-anilino-4′-(4,8-disulfonato-2-naphthylazo)-5′-methyl-3-sulfonatonaphthalene-2-azobenzene-1,2′-diolato]cuprate(II)

 

435-240-9

R52-53

R: 52/53

S: 61

 

 

611-168-00-5

mixture of: 3-[[4-chloro-6-[[7-[(1,5-disulfo-2-naphthalenyl)azo]-8-hydroxy-3,6-disulfo-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]-5-[[4-chloro-6-[[8-hydroxy-3,6-disulfo-7-[(2-sulfophenyl)azo]-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]benzoic acid;

3,5-bis[[4-chloro-6-[[7-[(1,5-disulfo-2-naphthalenyl)azo]-8-hydroxy-3,6-disulfo-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]benzoic acid

 

435-440-6

Xi; R41

Xi

R: 41

S: (2-)22-26-39

 

 

611-169-00-0

sodium 5-(2-carboxyphenylazo)-6-hydroxynaphthalene-2-sulfonate

 

435-800-2

R52-53

R: 52/53

S: 61

 

 

611-170-00-6

mixture of: trisodium 2-((1-(2-hydroxy-κ-O-5-(2-sulfonatoethansulfonyl)phenylazo-κ-N 2)-1-phenylmethyl)azo-κ-N 1)-4-sulfonatobenzoate(5-)-κ-O)cuprate(II);

disodium 2-((1-(5-ethenesulfonyl-2-hydroxy-κ-O-phenylazo-κ-N 2)-1-phenylmethyl)azo-κ-N 1)-4-sulfonatobenzoate-κ-O-(5-))cuprate(II)

 

435-880-9

R52-53

R: 52/53

S: 22-61

 

 

611-171-00-1

mixture of: trisodium 3-(5-(2,6-difluoropyrimidin-4-ylamino)-2-sulfonatophenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalenedisulfonate;

trisodium 3-(5-(4,6-difluoropyrimidin-2-ylamino)-2-sulfonatophenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalenedisulfonate

 

436-890-6

Xi; R41

R52-53

Xi

R: 41-52/53

S: (2-)22-26-39-61

 

 

611-172-00-7

mixture of: triammonium 6-amino-3-((2,5-diethoxy-4-(3-phosphonophenyl)azo)phenyl)azo-4-hydroxy-2-naphthalenesulfonate;

diammonium 3-((4-((7-amino-1-hydroxy-3-sulfo-naphthalen-2-yl)azo)-2,5-diethoxyphenyl)azo)benzoate

 

438-310-7

E; R2

Repr. Cat. 3; R62

Xn; R22-48/22

R52-53

E; Xn

R: 2-22-48/22-62-52/53

S: (2-)22-35-36/37-61

 

 

611-173-00-2

mixture of: 3-[3-carbamoyl-5-(5-{4-chloro-6-[4-(2-sulfonatooxyethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl]propanoic acid, trisodium salt;

3-[3-carbamoyl-5-(5-{4-chloro-6-[4-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl]propanoic acid, disodium salt

 

440-510-4

Xi; R41

R43

Xi

R: 41-43

S: (2-)22-26-36/37/39

 

 

611-174-00-8

mixture of: 3-[5-(4-ethenesulfonylbutyrylamino)-2-sulfophenylazo]-5-{4-chloro-[6-(4-(3-amino-5-hydroxy-2,7-disulfonaphthalene-4-ylazo)-3-sulfophenylamino]-1,3,5-triazin-2-ylamino}-4-hydroxynaphthalene-2,7-disulfonic acid, sodium salt;

3-[5-(4-(2-chloroethanesulfonyl)butyrylamino)-2-sulfophenylazo]-5-{4-chloro-[6-(4-(3-amino-5-hydroxy-2,7-disulfonaphthalene-4-ylazo)-3-sulfophenylamino]-1,3,5-triazin-2-ylamino}-4-hydroxynaphthalene-2,7-disulfonic acid, sodium salt

 

442-290-5

457624-86-1

Xi; R41

Xi

R: 41

S: (2-)22-26-39

 

 

611-175-00-3

mixture of: trisodium 5-{4-chloro-6-[N-ethyl-(3-(2-sulfonatooxy)ethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;

trisodium 5-{4-chloro-6-[N-ethyl-3-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;

disodium 5-{4-chloro-6-[N-ethyl-3-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[(4-vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;

tetrasodium 5-{4-chloro-6-[N-ethyl-3-(2-(sulfonatooxy)ethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-3-[4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo]-4-hydroxynaphthalene-2,7-disulfonate

 

444-050-5

Xi; R41

R52-53

Xi

R: 41-52/53

S: (2-)22-26-39-61

 

 

611-176-00-9

2,6-bis(2,3,4-trihydroxybenzyl)-p-cresol ester with 6-diazo-5,6-dihydro-5-oxo-1-naphthalenesulfonate

 

444-250-2

E; R2

F; R11

N; R51-53

E; N

R: 2-11-51/53

S: (2-)22-61

 

 

611-177-00-4

mixture of: pentasodium bis[6-anilino-3,5′-disulfonatonaphthalene-2-azobenzene-1,2′-diolato]cobaltate(III);

tetrasodium [6-anilino-3,5′-disulfonatonaphthalene-2-azobenzene-1,2′-diolato][6-anilino-5′-sulfamoyl-3-sulfonatonaphthalene-2-azobenzene-1,2′-diolato]cobaltate(III);

trisodium bis[6-anilino-5′-sulfamoyl-3-sulfonatonaphthalene-2-azobenzene-1,2′-diolato]cobaltate(III)

 

444-290-0

508202-43-5

Xi; R41

R43

R52-53

Xi

R: 41-43-52/53

S: (2-)22-24-26-37/39-61

 

 

611-178-00-X

mixture of: pentasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}naphthalene-2,7-disulfonate;

tetrasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;

tetrasodium 4-amino-5-hydroxy-6-[(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-3-[(E)-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;

trisodium 4-amino-5-hydroxy-3-[(E)-4-(vinylsulfonyl)phenylazo]-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;

trisodium 4-amino-5-hydroxy-3-[(2-hydroxyethylsulfonyl)-phenylazo]-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;

trisodium 4-amino-5-hydroxy-3-[(E)-4-(vinylsulfonyl)phenylazo]-6-[-2-sulfonato-4-(2-hydroxyethylsulfonyl)phenylazo]naphthalene-2,7-disulfonate

 

445-280-9

Xi; R41

R43

R52-53

Xi

R: 41-43-52/53

S: (2-)24-26-37/39-61

 

 

611-179-00-5

mixture of: pentasodium 2-[[8-[[4-chloro-6-[[4-(2-sulfonato ethylsulfonyl)]phenyl]amino]-1,3,5-triazin-2-yl]amino-1- hydroxy-3,6-disulfonato-2-naphthalenyl]azo]naphthalene-1,5-disulfonate;

2-[[8-[[4-chloro-6-[[4-[[2-ethenyl]sulfonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]-1-hydroxy-3,6-disulfonato-2-naphthalenyl]azo]naphthalene-1,5-disulfonate

 

450-010-8

Xi; R41

R43

Xi

R: 41-43

S: (2-)22-24-26-37/39

 

 

611-180-00-0

iron, complexes with diazotised 4-aminobenzenesulfonamide,diazotised 3-aminobenzenesulfonic acid, diazotised 3-amino-4-hydroxybenzenesulfonamide,diazotised 3-amino-4-hydroxy-N-phenylbenzenesulfonamide, diazotised 5-amino-2-(phenylamino)benzenesulfonic acid and resorcinol, sodium salts

 

417-850-7

N; R51-53

N

R: 51/53

S: 22-61

 

 

612-238-00-8

(3-chloro-2-hydroxypropyl) trimethylammonium chloride … %

B

222-048-3

3327-22-8

Carc. Cat. 3, R40

R52-53

Xn

R: 40-52/53

S: 36/37-61

 

 

612-239-00-3

biphenyl-3,3′,4,4′-tetrayltetraamine;

diaminobenzidine

 

202-110-6

91-95-2

Carc. Cat. 2; R45

Muta. Cat. 3; R68

T

R: 45-68

S: 53-45

 

 

612-240-00-9

pyrimethanil (ISO);

N-(4,6-dimethylpyrimidin-2-yl)aniline

 

53112-28-0

N; R51-53

N

R: 51/53

S: 61

 

 

612-241-00-4

piperazine hydrochloride; [1]

piperazine dihydrochloride; [2]

piperazine phosphate [3]

 

228-042-7 [1]

205-551-2 [2]

217-775-8 [3]

6094-40-2 [1]

142-64-3 [2]

1951-97-9 [3]

Repr. Cat. 3; R62-63

Xi; R36/38

R42/43

R52-53

Xn

R: 36/38-42/43-62-63-52/53

S: (1/2-)22-36/37-45-63-61

 

 

612-242-00-X

cyprodinil (ISO);

4-cyclopropyl-6-methyl-N-phenylpyrimidin-2-amine

 

121552-61-2

R43

N; R50-53

Xi; N

R: 43-50/53

S: (2-)24-37-46-60-61

C ≥ 2,5 %: Xi, N; R43-50/53

1 % ≤ C < 2,5 %: Xi, N; R43-51/53

0,25 % ≤ C < 1 %: N; R51/53

0,025 % ≤ C < 0,25 %: R52/53

 

612-243-00-5

(1S-cis)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine 2-hydroxy-2-phenylacetate

 

420-560-3

79617-97-3

Xi; R41

N; R50-53

Xi; N

R: 41-50/53

S: (2-)26-39-60-61

C ≥ 10 %: Xi, N; R41-50/53

5 % ≤ C < 10 %: Xi, N; R36-50/53

2,5 % ≤ C < 5 %: N; R50/53

0,25 % ≤ C < 2, 5 %: N; R51/53

0,025 % ≤ C < 0,25 %: R52/53

 

612-244-00-0

3-(piperazin-1-yl)-benzo[d]isothiazole hydrochloride

 

421-310-6

87691-88-1

Repr. Cat. 3; R62

Xn; R22

Xi; R36

R43

N; R50-53

Xn; N

R: 22-36-43-62-50/53

S: (2-)22-26-36/37/39-60-61

 

 

612-245-00-6

2-ethylphenylhydrazine hydrochloride

 

421-460-2

19398-06-2

Carc. Cat. 3; R40

T; R48/25

Xn; R22

Xi; R41

R43

N; R50-53

T; N

R: 22-40-41-43-48/25-50/53

S: (1/2-)22-26-36/37/39-45-60-61

C ≥ 25 %: T, N; R22-40-41-43-48/25-50/53

10 % ≤ C < 25 %: T, N; R40-41-43-48/25-50/53

5 % ≤ C < 10 %: Xn, N; R36-40-43-48/22-50/53

2,5 % ≤ C < 5 %: Xn, N; R40-43-48/22-50/53

1 % ≤ C < 2,5 %: Xn, N; R40-43-48/22-51/53

0,25 % ≤ C < 1 %: N; R51/53

0,025 % ≤ C < 0,25 %: R52/53

 

612-246-00-1

(2-chloroethyl)(3-hydroxypropyl)ammonium chloride

E

429-740-6

40722-80-3

Carc. Cat. 2; R45

Muta. Cat. 2; R46

Xn; R48/22

R43

R52-53

T

R: 45-46-43-48/22-52/53

S: 53-45-61

 

 

612-247-00-7

N-[3-(1,1-dimethylethyl)-1H-pyrazol-5-yl]-N′-hydroxy-4-nitrobenzenecarboximidamide

 

423-530-8

152828-23-4

T; R48/25

Xn; R22

R52-53

T

R: 22-48/25-52/53

S: (1/2-)22-36-45-61

 

 

612-248-00-2

reaction product of diphenylamine, phenothiazine, and alkenes, branched (C8-10, C9-rich)

 

439-540-0

Xi; R38

R43

R53

Xi

R: 38-43-53

S: (2-)24-37-61

 

 

612-249-00-8

4-[(3-chlorophenyl)(1H-imidazol-1-yl)methyl]-1,2-benzenediamine dihydrochloride

 

425-030-5

159939-85-2

Repr. Cat. 3; R62

Xn; R22

C; R34

R43

N; R51-53

C; N

R: 22-34-43-62-51/53

S: (1/2-)22-26-36/37/39-45-61

 

 

612-250-00-3

chloro-N,N-dimethylformiminium chloride

E

425-970-6

3724-43-4

R14

Repr. Cat. 2; R61

Xn; R22

C; R35

T; C

R: 61-14-22-35

S: 53-45

 

 

612-251-00-9

cis-1-(3-chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride

 

426-020-3

51229-78-8

F; R11

Repr. Cat. 3; R63

Xn; R22

Xi; R38

R43

N; R51-53

F; Xn; N

R: 11-22-38-43-63-51/53

S: (2-)7-22-33-36/37-61

 

 

612-252-00-4

imidacloprid (ISO);

1-(6-chloropyridin-3-ylmethyl)-N-nitroimidazolidin-2-ylidenamine

 

428-040-8

138261-41-3

Xn; R22

N; R50-53

Xn; N

R: 22-50/53

S: (2-)22-57-60-61

 

 

612-253-00-X

7-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one;

[containing < 0,5 % formamide (EC No 200-842-0)]

 

429-400-7

199327-61-2

R52-53

R: R52/53

S: 61

 

 

612-253-01-7

7-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one;

[containing ≥ 0,5 % formamide (EC No 200-842-0)]

 

429-400-7

199327-61-2

Repr. Cat. 2; R61

R52-53

T

R: 61-52/53

S: 53-45-61

 

 

612-254-00-5

reaction products of diisopropanolamine with formaldehyde (1:4)

 

432-440-8

220444-73-5

Carc. Cat. 3; R40

Xn; R22

C; R34

R43

N; R51-53

C; N

R: 22-34-40-43-51/53

S: (1/2-)13-25-26-36/37/39-45-61

 

 

612-255-00-0

1-(3-methoxypropyl)-4-piperidinamine

 

431-950-8

179474-79-4

Xn; R21/22

C; R34

R52-53

C

R: 21/22-34-52/53

S: (1/2-)26-36/37/39-45-61

 

 

612-256-00-6

benzyl(S)-2-[(2′-cyanobiphenyl-4-ylmethyl)pentanoylamino]-3-methylbutyrate

 

427-470-3

137864-22-3

Xn; R22

R43

Xn

R: 22-43

S: (2-)36/37

 

 

612-257-00-1

tripropylammonium dihydrogenphosphate

 

433-700-3

35687-90-2

Xn; R22

Xn

R: 22

S: (2-)22

 

 

612-259-00-2

N-ethyl-3-trimethoxysilyl-2-methyl-propanamine

 

437-720-3

227085-51-0

Xi; R41

Xi

R: 41

S: (2-)26-39

 

 

612-261-00-3

3,5-dichloro-2-fluoro-4-(1,1,2,3,3,3-hexafluoropropoxy)aniline

 

441-190-9

121451-05-6

Xn; R22

R43

N; R50-53

Xn; N

R: 22-43-50/53

S: (2-)24-37-60-61

C ≥ 25 %: Xn, N; R22-43-50/53

2,5 % ≤ C < 25 %: Xi, N; R43-50/53

1 % ≤ C < 2,5 %: Xi, N; R43-51/53

0,25 % ≤ C < 1 %: N; R51/53

0,025 % ≤ C < 0,25 %: R52/53

 

612-265-00-5

bis(2-hydroxyethyl)-(2-hydroxypropyl)ammonium acetate

 

444-360-0

191617-13-7

R52-53

R: 52/53

S: 61

 

 

612-266-00-0

3-chloro-4-(3-fluorobenzyloxy)aniline

 

445-590-4

202197-26-0

Muta. Cat. 3; R68

Xn; R22-48/22

N; R50-53

Xn; N

R: 22-48/22-68-50/53

S: (2-)22-36/37-60-61

 

 

612-267-00-6

bis(hydrogenated tallow C16-18-alkyl)hydroxylamine

 

418-370-0

R43

R53

Xi

R: 43-53

S: (2-)36/37-61

 

 

612-269-00-7

mixture of: 1-[di(4-octylphenyl)aminomethyl]-5-methyl-1H-benzotriazole;

1-[di(4-octylphenyl)aminomethyl]-4-methyl-1H-benzotriazole;

mixture of: N-[(5-methyl-1H-benzotriazol-1-yl)methyl]-4-octyl-N-(4-octylphenyl)aniline;

N-[(4-methyl-1H-benzotriazol-1-yl)methyl]-4-octyl-N-(4-octylphenyl)aniline

 

420-720-2

R53

R: 53

S: 22-61

 

 

612-270-00-2

(S)-azetidine-2-carboxylic acid 4-cyanobenzylamide hydrochloride

 

433-010-2

Xn; R22

R43

R52-53

Xn

R: 22-43-52/53

S: (2-)22-36/37-61

 

 

612-271-00-8

mixture of: ethyl 2-((4-(5,6-dichlorobenzothiazol-2-ylazo)phenyl)ethylamino)benzoate;

ethyl 2-((4-(6,7-dichlorobenzothiazol-2-ylazo)phenyl)ethylamino)benzoate

 

434-970-5

160987-57-5

R53

R: 53

S: 61

 

 

612-272-00-3

ammonium (η-6-2-(2-(1,2-dicarboxylatoethylamino)ethylamino)butane-1,4-dioato(4-))iron(3+) monohydrate

 

435-210-5

N; R51-53

N

R: 51/53

S: 61

 

 

612-273-00-9

alkyl(rapeseed oil), bis(2-hydroxyethyl)ammonium fluoride

 

435-650-8

Xn; R22

C; R35

N; R50-53

C; N

R: 22-35-50/53

S: (1/2-)26-36/37/39-45-60-61

 

 

612-274-00-4

(R,S)-1-[2-amino-1(4-methoxyphenyl)ethyl]cyclohexanol acetate

 

445-750-3

Xn; R22

Xi; R41

R43

R52-53

Xn

R: 22-41-43-52/53

S: (2-)22-24-26-37/39-61

 

 

612-275-00-X

fatty acids, C18-unsatd., dimers, reaction products with 1-piperazineethanamine and tall oil

 

447-880-6

206565-89-1

Xi; R38-41

R43

N; R50-53

Xi; N

R: 38-41-43-50/53

S: (2-)23-26-36/37/39-60-61

C ≥ 20 %: Xi, N; R38-41-43-50/53

10 % ≤ C < 20 %: Xi, N; R41-43-50/53

5 % ≤ C < 10 %: Xi, N; R36-43-50/53

2,5 % ≤ C < 5 %: Xi, N; R43-50/53

1 % ≤ C < 2,5 %: Xi, N; R43-51/53

0,25 % ≤ C < 1 %: N; R51/53

0,025 % ≤ C < 0,25 %: R52/53

 

612-276-00-5

1-amino-4-[(4-amino-2-sulfofenyl)amino]-9,10-dihydro-9,10-dioxo-2-anthracenesulfonic acid, disodium salt, reaction products with 2-[[3-[(4,6-dichloro-1,3,5-triazin-2-yl)ethylamino]phenyl]sulfonyl]ethyl hydrogen sulfate, sodium salts

 

451-430-4

500717-36-2

Xi; R41

R43

R52-53

Xi

R: 41-43-52/53

S: (2-)22-24-26-36/37/39-61

 

 

612-277-00-0

mixture of: 4-amino-3-(4-ethenesulfonyl-2-sulfonatophenylazo)-5-hydroxy-6-(5-{4-chloro-6-[4-(2-sulfonatooxyethanesulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)naphthalene-2,7-disulfonate potassium/sodium;

4-amino-5-hydroxy-6-(5-{4-chloro-6-[4-(2-sulfonatooxyethanesulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-3-(2-sulfonato-4-(2-sulfonatooxyethanesulfonyl)phenylazo)naphthalene-2,7-disulfonate potassium/sodium

 

451-440-9

586372-44-3

Xi; R41

Xi

R: 41

S: (2-)22-26-39

 

 

612-278-00-6

ethidium bromide;

3,8-diamino-1-ethyl-6-phenylphenantridinium bromide

 

214-984-6

1239-45-8

Muta. Cat. 3; R68

T+; R26

Xn; R22

T+

R: 22-26-68

S: (1/2-)28-36/37-45-63

 

 

612-279-00-1

(R,S)-2-amino-3,3-dimethylbutane amide

 

447-860-7

144177-62-8

Repr. Cat. 3; R62

Xn; R48/22

Xi; R36/38

R43

Xn

R: 36/38-43-48/22-62

S: (2-)22-26-36/37

 

 

612-280-00-7

3-amino-9-ethyl carbazole;

9-ethylcarbazol-3-ylamine

H

205-057-7

132-32-1

Carc. Cat. 2; R45

T

R: 45

S: 53-45

 

 

613-116-01-4

tolylfluanid (ISO);

dichloro-N-[(dimethylamino)sulphonyl]fluoro-N-(p-tolyl)methanesulphenamide;

[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]

 

211-986-9

731-27-1

Xi; R36/37/38

R43

N; R50

Xi; N

R: 36/37/38-43-50

S: (2-)25-36/37-46-61

C ≥ 20 %: Xi, N; R36/37/38-43-50

2,5 % ≤ C < 20 %: Xi, N; R43-50

1 % ≤ C < 2,5 %: Xi; R43

 

613-280-00-X

tetrahydro-1,3-dimethyl-1H-pyrimidin-2-one;

dimethyl propyleneurea

 

230-625-6

7226-23-5

Repr. Cat. 3; R62

Xn; R22

Xi; R41

Xn

R: 22-41-62

S: 26-36/37/39

 

 

613-281-00-5

quinoline

E

202-051-6

91-22-5

Carc. Cat. 2; R45

Muta. Cat. 3; R68

Xn; R21/22

Xi; R36/38

N; R51-53

T; N

R: 45-21/22-36/38-68-51/53

S: 53-45-61

 

 

613-282-00-0

triticonazole (ISO);

(RS)-(E)-5-(4-chlorobenzylidene)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-methyl)cyclopentanol

 

131983-72-7

N; R51-53

N

R: 51/53

S: 61

 

 

613-283-00-6

ketoconazole;

1-[4-[4-[[(2SR,4RS)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone

E

265-667-4

65277-42-1

Repr. Cat. 2; R60

T; R25

Xn; R48/22

N; R50-53

T; N

R: 60-25-48/22-50/53

S: 53-45-60-61

 

 

613-284-00-1

metconazole (ISO);

(1RS,5RS;1RS,5SR)-5-(4-chlorobenzyl)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol

 

125116-23-6

Repr. Cat. 3; R63

Xn; R22

N; R51-53

Xn; N

R: 22-63-51/53

S: (2-)36/37-46-61

 

 

613-285-00-7

1-hydroxybenzotriazole, anhydrous; [1]

1-hydroxybenzotriazole, monohydrated [2]

 

219-989-7 [1]

219-989-7 [2]

2592-95-2 [1]

123333-53-9 [2]

E; R2

E

R: 2

S: 16-35

 

 

613-286-00-2

potassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-ylidene)-1-propenyl]pyrazole-5-olate;

[containing < 0,5 % N,N-dimethylformamide (EC No 200-679-5)]

 

418-260-2

183196-57-8

R43

Xi

R: 43

S: (2-)24-37

 

 

613-286-01-X

potassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-ylidene)-1-propenyl]pyrazole-5-olate;

[containing ≥ 0,5 % N,N-dimethylformamide (EC No 200-679-5)]

 

418-260-2

183196-57-8

Repr. Cat. 2; R61

R43

T

R: 61-43

S: 53-45

 

 

613-287-00-8

1-(3-iodo-4-aminobenzyl)-1H-1,2,4-triazole

 

419-540-7

160194-26-3

Xn; R22

R43

N; R51-53

Xn; N

R: 22-43-51/53

S: (2-)24-37-61

 

 

613-288-00-3

1,3-bis(dimethylcarbamoyl)-imidazolium chloride

 

420-930-4

135756-61-5

Xn; R22

Xi; R41

R52-53

Xn

R: 22-41-52/53

S: (2-)22-26-37/39-61

 

 

613-289-00-9

3-(4-chloro-2-fluoro-5-methylphenyl)-1-methyl-5-(trifluoromethyl)-1H-pyrazole

 

432-020-4

142623-48-1

N; R50-53

N

R: 50/53

S: 60-61

 

 

613-290-00-4

4-hydroxy-7-(2-aminoethyl)-1,3-benzothiazol-2(3H)-one hydrochloride

 

432-470-1

189012-93-9

Xi; R41

R43

N; R50-53

Xi; N

R: 41-43-50/53

S: (2-)24-26-37/39-60-61

 

 

613-291-00-X

2,4-dihydro-4-(4-(4-(4-hydroxyphenyl)-1-piperazinyl)phenyl)-2-(1-methylpropyl)-3H-1,2,4-triazol-3-one

 

434-820-9

106461-41-0

Xn; R48/22

N; R50-53

Xn; N

R: 48/22-50/53

S: (2-)22-36-60-61

 

 

613-292-00-5

N,N′,N″-tris(2-methyl-2,3-epoxypropyl)-perhydro-2,4,6-oxo-1,3,5-triazine

 

435-010-8

26157-73-3

Muta. Cat. 3; R68

R52-53

Xn

R: 68-52/53

S: (2-)36/37-61

 

 

613-293-00-0

2-(4-tert-butylphenyl)-6-cyano-5-[bis(ethoxycarbonylmethyl)carbamoyloxy]-1H-pyrrolo[1,2-b][1,2,4] triazole-7-carboxylic acid 2,6-di-tert-butyl-4-methylcyclohexylester

 

448-050-6

444065-11-6

R53

R: 53

S: 61

 

 

613-294-00-6

2-hexyldecanoic acid [4-(6-tert-butyl-7-chloro-1H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenylcarbamoyl]methylester

 

448-260-8

379268-96-9

R53

R: 53

S: 61

 

 

613-295-00-1

11-amino-3-chloro-6,11-dihydro-5,5-dioxo-6-methyl-dibenzo[c,f][1,2]thiazepine hydrochloride

 

448-720-8

363138-44-7

Xn; R22

Xi; R41

R52-53

Xn

R: 22-41-52/53

S: (2-)22-26-39-61

 

 

613-296-00-7

pentapotassium 2-(4-(5-[1-(2,5-disulfonatophenyl)-4,5-dihydro-3-methylcarbamoyl-5-oxopyrazol-4-ylidene]-3-methyl-1,3-pentadienyl)-3-methylcarbamoyl-5-oxidopyrazol-1-yl)benzene-1,4-disulfonate

 

418-270-7

R43

R52-53

Xi

R: 43-52/53

S: (2-)24-37-47-61

 

 

613-297-00-2

5-(2-bromophenyl)-2-tert-butyl-2H-tetrazole

 

420-820-6

R10

Xn; R22

N; R51-53

Xn; N

R: 10-22-51/53

S: (2-)16-61

 

 

613-298-00-8

bis-(6-hydroxy-4-methyl-5-(3-methylimidazolium-1-yl)-3-(4-phenylazo)-1H-pyridin-2-one)ethylene dilactate

 

421-560-6

Xn; R48/22

Xi; R41

N; R51-53

Xn; N

R: 41-48/22-51/53

S: (2-)22-26-36/39-61

 

 

613-299-00-3

main component 1 (isomer 1): 2-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonapht-7-ylamino]-1,3,5-triazin-2-ylamino}-3-{6-fluoro-4-[3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt;

main component 1 (isomer 2): 2-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-3-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt;

main component 2: 2,3-bis-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt;

main component 3: 2,3-bis-{6-fluoro-4-[3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt

 

422-610-1

Xi; R41

Xi

R: 41

S: (2-)22-26-39

 

 

613-300-00-7

1-imidazol-1-yl-octadecan-2-ol

 

434-120-3

R43

R53

Xi

R: 43-53

S: (2-)24-37-61

 

 

613-301-00-2

dimethyl-1-{[2-methoxy-5-(2-methyl-butoxycarbonyl)phenylcarbamoyl]-[2-octadecyl-1,1-dioxo-1,2,4-benzothiadiazin-3-yl]methyl} imidazole-4,5-dicarboxylate

 

443-910-7

R53

R: 53

S: 61

 

 

613-302-00-8

disodium 2-(5-carbamoyl-1-ethyl-2-hydroxy-4-methyl-6-oxo-1,6-dihydro-pyridine-3-ylazo)-4-(4-fluoro-6-(4-(2-sulfonyloxy-ethylsulfonyl)-phenylamino)-1,3,5-triazine-2-ylamino)benzene sulfonate

 

432-980-4

243858-60-8

Xi; R41

Xi

R: 41

S: (2-)22-26-39

 

 

613-303-00-3

2-(1-methyl-2-(4-phenoxyphenoxy)ethoxy)pyridine

 

429-800-1

95737-68-1

N; R50-53

N

R: 50/53

S: 60-61

 

 

613-304-00-9

5,6-dihydroxy-2,3-dihydro-1H-indolium bromide

 

421-170-6

138937-28-7

Xn; R22

Xi; R41

Xn

R: 22-41

S: (2-)22-26-39

 

 

613-305-00-4

2-(2-hydroxy-4-octyloxyphenyl)-2H-benzotriazole

 

448-630-9

3147-77-1

R53

R: 53

S: 61

 

 

613-306-00-X

(2,5-dioxopyrrolidin-1-yl)-9H-fluoren-9-ylmethyl carbonate

 

433-520-5

82911-69-1

Xn; R22

R43

N; R51-53

Xn; N

R: 22-43-51/53

S: (2-)24-37-61

 

 

613-307-00-5

clothianidin (ISO);

3-[(2-chloro-1,3-thiazol-5-yl)methyl]-2-methyl-1-nitroguanidine

 

210880-92-5

Xn; R22

N; R50-53

Xn; N

R: 22-50/53

S: (2-)46-60-61

C ≥ 25 %: Xn, N; R22-50/53

2,5 % ≤ C < 25 %: N; R50/53

0,25 % ≤ C < 2,5 %: N; R51/53

0,025 % ≤ C < 0,25 %: R52/53

 

613-308-00-0

2-amino-5-methylthiazole

 

423-800-5

7305-71-7

Xn; R22-48/22

N; R50-53

Xn; N

R: 22-48/22-50/53

S: (2-)22-36-60-61

 

 

613-309-00-6

1-methyl-3-phenyl-1-piperazine

 

431-180-2

5271-27-2

Xn; R21/22

Xi; R38-41

R52-53

Xn

R: 21/22-38-41-52/53

S: (2-)26-36/37/39-61

 

 

613-310-00-1

(-)(3S,4R)-4-(4-fluorophenyl)-3-(3,4-methylenedioxy-phenoxymethyl)-N-benzylpiperidine hydrochloride

 

432-360-3

105813-13-6

Xn; R22

R43

N; R50-53

Xn; N

R: 22-43-50/53

S: (2-)22-24-37-60-61

 

 

613-311-00-7

methyl-5-nitrophenyl-guanidine

 

435-500-1

152460-07-6

Xn; R22

Xi; R36

R43

R52-53

Xn

R: 22-36-43-52/53

S: (2-)22-24-26-37-61

 

 

613-312-00-2

2-(4-methyl-2-phenyl-1-piperazinyl)benzenemethanol monohydrochloride

 

420-200-5

Xn; R22

Xi; R41

R43

R52-53

Xn

R: 22-41-43-52/53

S: (2-)22-26-36/37/39-61

 

 

613-313-00-8

2-(4-(4-(3-pyridinyl)-1H-imidazol-1-yl)butyl)-1H-isoindole-1,3(2H)-dione

 

442-780-9

173838-67-0

R52-53

R: 52/53

S: 61

 

 

613-314-00-3

4-decyloxazolidin-2-one;

4-decyl-1,3-oxazolidin-2-one

 

443-770-7

7693-82-5

N; R50-53

N

R: 50/53

S: 22-24-60-61

 

 

613-315-00-9

tetrapotassium 4-[5-[3-carboxylato-4,5-dihydro-5-oxo-1-(4-sulfonatophenyl)pyrazol-4-ylidene]-3-(piperidinocarbonyl)penta-1,3-dienylidene]-5-hydroxy-1-(4-sulfonatophenyl)pyrazole-3-carboxylate

 

430-390-1

Xn; R20

R52-53

Xn

R: 20-52/53

S: (2-)25-61

 

 

613-316-00-4

trimethylopropane tri(3-aziridinylpropanoate);

(TAZ)

H

257-765-0

52234-82-9

Muta. Cat. 3; R68

Xi; R41

R43

Xn

R: 41-43-68

S: 26-36/37/39-42

 

 

615-044-00-1

4-chlorophenylisocyanate

 

203-176-9

104-12-1

T+; R26

Xn; R22

Xi; R37/38-41

R42

N; R50-53

T+; N

R: 22-26-37/38-41-42-50/53

S: (1/2-)26-28-36/37/39-45-63-60-61

 

 

615-045-00-7

4,4′-methylene bis(3-chloro-2,6-di-ethylphenylisocyanate)

 

420-530-1

R42/43

R53

Xn

R: 42/43-53

S: (2-)23-24-37-45-61

 

 

616-126-00-X

1-methyl-4-nitro-3-propyl-1H-pyrazole-5-carboxamide

 

423-960-6

139756-01-7

Xn; R22-48/22

R52-53

Xn

R: 22-48/22-52/53

S: (2-)22-36/37-61

 

 

616-164-00-7

dimoxystrobin (ISO);

(E)-2-(methoxyimino)-N-methyl-2-[α-(2,5-xylyloxy)-o-tolyl]acetamide

 

149961-52-4

Carc. Cat. 3; R40

Repr. Cat. 3; R63

Xn; R20

N; R50-53

Xn; N

R: 20-40-63-50/53

S: (2-)36/37-46-60-61

C ≥ 25 %: Xn, N; R20-40-63-50/53

5 % ≤ C < 25 %: Xn, N; R40-63-50/53

2,5 % ≤ C < 5 %: Xn, N; R40-50/53

1 % ≤ C < 2,5 %: Xn, N; R40-51/53

0,25 % ≤ C < 1 %: N; R51/53

0,025 % ≤ C < 0,25 %: R52-53

 

616-165-00-2

beflubutamid (ISO);

(RS)-N-benzyl-2-(α,α,α,4-tetrafluoro-m-tolyoxy)butyramide

 

113614-08-7

N; R50-53

N

R: 50/53

S: 60-61

C ≥ 0,25 %: N; R50/53

0,025 % ≤ C < 0,25 %: N; R51/53

0,0025 % ≤ C < 0,025 %: R52/53

 

616-166-00-8

cyazofamid (ISO);

4-chloro-2-cyano-N,N-dimethyl-5-p-tolylimidazole-1-sulfonamide

 

120116-88-3

N; R50-53

N

R: 50/53

S: 60-61

C ≥ 2,5 %: N; R50/53

0,25 % ≤ C < 2,5 %: N; R51-53

0,025 % ≤ C < 0,25 %: R52/53

 

616-167-00-3

N,N-dibutyl-(2,5-dihydro-5-thioxo-1H-tetrazol-1-yl)acetamide

 

418-290-6

168612-06-4

Xi; R36

R43

Xi

R: 36-43

S: (2-)24-26-37

 

 

616-168-00-9

1-dimethylcarbamoyl-4-(2-sulfonatoethyl)pyridinium

 

418-440-0

136997-71-2

R43

Xi

R: 43

S: (2-)22-24-37

 

 

616-169-00-4

4-[4-(2,2-dimethyl-propanamido)]phenylazo-3-(2-chloro-5-(2-(3-pentadecylphenoxy)butylamido)anilino)-1-(2,4,6-trichlorophenyl)-2-pyrazoline-5-one

 

420-220-4

92771-56-7

R43

R53

Xi

R: 43-53

S: (2-)24-37-61

 

 

616-170-00-X

(2R)-2-amino-2-phenylacetamide

 

420-370-0

6485-67-2

Xi; R36

R43

Xi

R: 36-43

S: (2-)22-26-36/37

 

 

616-171-00-5

2-(para-chlorophenyl)glycineamide

 

420-830-0

102333-75-5

Xi; R41

R43

Xi

R: 41-43

S: (2-)24-26-37/39

 

 

616-172-00-0

N-(2,2,6,6-tetramethyl-1-oxylpiperidin-4-yl)acetamide;

(4-acetamido-2,2,6,6-tetramethyl-1-piperidinyl)oxidanyl

 

423-840-3

14691-89-5

Xn; R22

Xn

R: 22

S: (2-)22

 

 

616-174-00-1

2-butyl-1,3-diazaspiro[4.4]non-1-en-4-one hydrochloride

 

424-560-4

151257-01-1

Xn; R22

Xi; R36

Xn

R: 22-36

S: (2-)22-26

 

 

616-175-00-7

2-(2-hexyldecyloxy)benzamide

 

431-230-3

202483-62-3

R53

R: 53

S: 61

 

 

616-176-00-2

3-N,N-bis(methoxyethyl)aminoacetanilide

 

432-530-7

24294-01-7

Xn; R22

R52-53

Xn

R: 22-52/53

S: (2-)22-24-61

 

 

616-177-00-8

(3-(4-(2-(butyl-(4-methylphenylsulfonyl)amino)phenylthio)-5-oxo-1-(2,4,6-trichlorophenyl)-4,5-dihydro-1H-pyrazole-3-ylamino)-4-chlorophenyl)tetradecanamide;

N-[3-({4-[(2-{butyl[(4-methylphenyl)sulfonyl]amino}phenyl)thio]-5-oxo-1-(2,4,6-trichlorophenyl)-4,5-dihydro-1H-pyrazol-3-yl}amino)-4-chlorophenyl]tetradecanamide

 

432-970-1

217324-98-6

R53

R: 53

S: 61

 

 

616-178-00-3

N-(5-(bis(2-methoxyethyl)amino)-2-((2-cyano-4,6-dinitrophenyl)-azo)phenyl)acetamide

 

434-500-9

52583-35-4

R53

R: 53

S: 22-61

 

 

616-179-00-9

2-chloro-N-(4-methylphenyl)acetamide

 

435-170-9

16634-82-5

Xi; R41

R43

N; R50-53

Xi; N

R: 41-43-50/53

S: (2-)22-26-36/37/39-60-61

 

 

616-180-00-4

N,N-(dimethylamino)thioacetamide hydrochloride

 

435-470-1

27366-72-9

Repr. Cat. 2; R61

N; R50-53

T; N

R: 61-50/53

S: 53-45-60-61

 

 

616-181-00-X

4′-methyldodecane-1-sulfonanilide

 

435-490-9

17417-32-2

N; R50-53

N

R: 50/53

S: 60-61

 

 

616-182-00-5

N′-(1,3-dimethylbutylidene)-3-hydroxy-2-naphthohydrazide

 

435-860-1

214417-91-1

R43

N; R51-53

Xi; N

R: 43-51/53

S: (2-)24-37-61

 

 

616-183-00-0

N-dodecyl-4-methoxybenzamide

 

442-340-6

1854-15-5

R53

R: 53

S: 61

 

 

616-184-00-6

3-methyl-N-(5,8,13,14-tetrahydro-5,8,14-trioxonaphth[2,3-c]acridin-6-yl)benzamide

 

442-560-2

105043-55-8

R53

R: 53

S: 61

 

 

616-186-00-7

N,N′-(2-chloro-1,4-phenylene)bis(3-oxobutaneamide)

 

443-010-4

53641-10-4

R52-53

R: 52/53

S: 61

 

 

616-188-00-8

2-(5,5-dimethyl-2,4-dioxooxazolidin-3-yl)-4,4-dimethyl-3-oxo-N-(2-methoxy-5-octadecanoylaminophenyl)pentanoic acid amide

 

443-980-9

221215-20-9

R43

R53

Xi

R: 43-53

S: (2-)24-37-61

 

 

616-189-00-3

N-[5-(bis-(2-methoxy-ethyl)-amino]-2-(6-bromo-2-methyl-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)-phenyl]acetamide

 

444-780-4

452962-97-9

R53

R: 53

S: 61

 

 

616-190-00-9

N-decyl-4-nitrobenzamide

 

445-880-0

64026-19-3

R53

R: 53

S: 61

 

 

616-191-00-4

2-ethyl-N-methyl-N-(3-methylphenyl)butanamide

 

446-190-2

406488-30-0

Xn; R22

Xi; R36/38

R43

N; R51-53

Xn; N

R: 22-36/38-43-51/53

S: (2-)24-26-37-61

 

 

616-192-00-X

2-[2-(3-butoxypropyl)-1,1-dioxo-1,2,4-benzothiadiazin-3-yl]-5′-tert-butyl-2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-2′-[(2-ethylhexyl)thio]acetanilide

 

448-060-0

727678-39-9

R53

R: 53

S: 61

 

 

616-193-00-5

N-[2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)-5-diethylamino-phenyl]acetamide

 

449-940-7

368450-39-9

R53

R: 53

S: 61

 

 

616-194-00-0

2,2-diethoxy-N,N-dimethylacetamide

 

449-950-1

34640-92-1

Xi; R36

Xi

R: 36

S: (2-)26

 

 

616-196-00-1

disodium salt of 1-hydroxy-4-(β-(4-(1-hydroxy-3,6-disulfo-8-acetylamino-2-naphthylazo)phenoxy)ethoxy)-N-dodecyl-2-naphthamide

 

419-990-4

N; R50-53

N

R: 50/53

S: 60-61

 

 

616-197-00-7

mixture of: potassium N-[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane sulfonamidate;

N-[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane sulfonamide

 

422-500-1

Xn; R48/22

Xn

R: 48/22

S: (2-)22-36

 

 

616-198-00-2

1,3-bis[12-hydroxy-octadecamide-N-methylene]-benzene

 

423-300-7

R43

R53

Xi

R: 43-53

S: (2-)24-37-61

 

 

616-200-00-1

mixture of: N,N′-ethane-1,2-diylbis(hexanamide);

12-hydroxy-N-[2-[(1-oxyhexyl)amino]ethyl]octadecanamide;

N,N′-ethane-1,2-diylbis(12-hydroxyoctadecanamide)

 

432-430-3

R43

R53

Xi

R: 43-53

S: (2-)24-37-61

 

 

616-201-00-7

12-hydroxyoctadecanoic acid, reaction products with 1,3-benzenedimethanamine and hexamethylenediamine

 

432-840-2

220926-97-6

Xn; R20

R53

Xn

R: 20-53

S: (2-)22-61

 

 

616-202-00-2

mixture of: 2,2′-[(3,3′-dichloro[1,1′-biphenyl]-4,4′-diyl)bis(azo)]bis[N-(2,4-dimethylphenyl)]-3-oxo-butanamide;

2-[[3,3′-dichloro-4′-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1′-biphenyl]-4-yl]azo]-N-(2-methylphenyl)-3-oxo-butanamide;

2-[[3,3′-dichloro-4′-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1′-biphenyl]-4-yl]azo]-N-(2-carboxylphenyl)-3-oxo-butanamide

 

434-330-5

Carc. Cat. 3; R40

R43

R53

Xn

R: 40-43-53

S: (2-)36/37-61

 

 

616-203-00-8

mixture of: N-[5-[bis-(2-methoxyethyl)amino]-2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-yl-azo)phenyl]acetamide;

N-[2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)5-diethylaminophenyl]acetamide

 

442-280-0

R53

R: 53

S: 61

 

 

616-204-00-3

N,N″-(methylenedi-4,1-phenylene)bis[N′-octylurea]

 

451-060-3

122886-55-9

R53

R: 53

S: 61

 

 

617-022-00-7

mixture of: 1,2-dimethylpropylidene dihydroperoxide;

dimethyl 1,2-benzenedicarboxylate

 

442-480-8

O; R7

Xn; R22

C; R34

R43

N; R51-53

O; C; N

R: 7-22-34-43-51/53

S: (1/2-)3/7-14-26-36/37/39-45-50-61

 

 

647-017-00-5

laccase

 

420-150-4

80498-15-3

R42

Xn

R: 42

S: (2-)23-45

 

 


ANNEX 1C

The entries in Annex I with the following Index numbers are deleted:

024-004-01-4, 603-037-01-3, 603-155-00-8, and 611-084-00-9.


Top